Wet age-related macular degeneration

WET_AMD

age-related macular degeneration: Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions not WET_AMD_EARLY	557604
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE>=50 Registry filters: Hospital discharge: ICD-10 — H35.31 Hospital discharge: ICD-9 — 3625B Cause of death: ICD-10 — H35.31 Cause of death: ICD-9 — 3625B 2 out of 7 registries used, show all original rules.	9107
4. Check minimum number of events None	9107
5. Include endpoints None	9107
6. Filter based on genotype QC (FinnGen only)	8145

Control definitions (FinnGen only)

Control exclude: H7_RETINOPATHYDIAB, H7_RETINASEPAR, MACULA_NAS, H7_GLAUCPRIMOPEN, H7_GLAUCCLOSEPRIM, H7_GLAUCSECTRAUMA, H7_GLAUCSECINFLAM, H7_GLAUCSECDISEASE, H7_GLAUCSECDRUG, H7_GLAUCNAS
Control pre-conditions: DEATH_AGE>=50
Control conditions: not WET_AMD_EARLY

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H35
Name in latin: Degeneratio maculae senilis exsudativa

NAME	WET_AMD
CONTROL_EXCLUDE	H7_RETINOPATHYDIAB\|H7_RETINASEPAR\|MACULA_NAS\|H7_GLAUCPRIMOPEN\|H7_GLAUCCLOSEPRIM\|H7_GLAUCSECTRAUMA\|H7_GLAUCSECINFLAM\|H7_GLAUCSECDISEASE\|H7_GLAUCSECDRUG\|H7_GLAUCNAS
CONTROL_PRECONDITIONS	DEATH_AGE>=50
CONTROL_CONDITIONS	!WET_AMD_EARLY
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE>=50
CONDITIONS	!WET_AMD_EARLY
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H3531
HD_ICD_9	3625B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H3531
COD_ICD_9	3625B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Wet age-related macular degeneration based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	55712	35752	19781
Only index persons	52323	33890	18433
Unadjusted period prevalence (%)
Whole population	0.85	1.02	0.55
Only index persons	1.05	1.25	0.70
Median age at first event (years)
Whole population	79.09	80.01	77.43
Only index persons	79.02	79.96	77.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8145	4392	3753
Unadjusted period prevalence (%)	1.63	1.56	1.72
Median age at first event (years)	77.35	77.62	77.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8363: Matched controls
80590

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX140

NOMESCO Finland

Parabulbar anesthesy

4.8

312.6

760

1641

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

4503599627370496.0

307.7

8354

149

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

71.4

307.7

618

H35.6

ICD-10 Finland

Retinal haemorrhage

21.1

307.7

309

146

XCW99

NOMESCO Finland

Other investigative procedure of eye

10.1

307.7

2995

4232

114

Kela drug reimbursment

Glaucoma

6.5

307.7

1139

1918

XCW10

NOMESCO Finland

Assessment of vision

19.8

307.7

521

269

S01ED51

ATC

timolol, combinations; ophthalmic

6.8

307.7

1035

1641

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.2

307.7

5694

31984

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

16.0

307.7

3398

3308

S01EC04

ATC

brinzolamide; ophthalmic

10.1

307.7

497

502

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

27.4

307.7

380

140

1LA05, ,

NOMESCO Finland

383.6

307.7

380

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

155.4

307.7

709

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

18.2

307.7

3639

3279

XCH00

NOMESCO Finland

Eye pressure measurement

8.9

307.7

1198

1488

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

116.6

307.7

292

XCD20

NOMESCO Finland

Photoangiography of eye

57.2

307.7

1097

212

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

14.3

307.7

348

244

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

84.8

307.7

346

ZX198

NOMESCO Finland

Other local administration

56.8

307.7

582

106

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

60.2

307.7

416

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

384.8

307.7

6062

548

ZXA10

NOMESCO Finland

Bilateral

2.8

307.7

2630

11294

H35.7

ICD-10 Finland

Separation of retinal layers

3406.6

307.7

349

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

115.0

307.7

473

H36.01

ICD-10 Finland

Diabetic maculopathy

141.7

307.7

201

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

154.9

307.7

980

Z96.1

ICD-10 Finland

Presence of intraocular lens

4.1

307.7

3061

9860

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.6

307.7

2763

7735

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

15.1

307.7

395

263

S01EA05

ATC

brimonidine; ophthalmic

14.8

307.7

308

207

XCK10

NOMESCO Finland

Photography of fundus of eye

6.2

307.7

2037

3964

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

49.8

307.7

342

H25.1

ICD-10 Finland

Senile nuclear cataract

2.7

307.7

4845

27051

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

11.2

307.7

1902

2058

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

124.9

307.7

227

S01EE01

ATC

latanoprost; ophthalmic

6.0

307.7

824

1452

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.9

305.2

1712

6482

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

296.7

4816

29768

H26.4

ICD-10 Finland

After-cataract

2.7

295.4

1964

8124

H40.11

ICD-10 Finland

Low pressure glaucoma

28.1

275.5

191

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

9.2

259.0

324

351

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.2

258.4

4207

25519

H40.9

ICD-10 Finland

Glaucoma, unspecified

19.8

246.1

195

CKC12

NOMESCO Finland

Photocoagulation of retina

5.5

236.6

485

899

XCK00

NOMESCO Finland

Perimetry

4.0

235.2

715

1826

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

6.3

222.1

386

610

S01EC54

ATC

brinzolamide, combinations; ophthalmic

20.4

217.3

170

H34.8

ICD-10 Finland

Other retinal vascular occlusions

5.1

206.3

452

888

CKC10

NOMESCO Finland

Local photocoagulation of retina

7.5

206.1

306

408

H3601, E113,

ICD-10 Finland

+∞

201.1

195

S01EC01

ATC

acetazolamide; systemic

8.7

195.7

254

288

S01ED01

ATC

timolol; ophthalmic

5.3

193.6

405

763

S01EE05

ATC

tafluprost; ophthalmic

5.6

177.3

348

618

S01EE03

ATC

bimatoprost; ophthalmic

8.5

173.6

229

265

Z3229

NOMESCO Finland

Other healthcare associate professional

2.6

169.2

1081

4286

A98

ICPC

Health maint/preventive medicine

2.8

166.0

7613

63064

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

7.5

165.4

242

317

H36.00

ICD-10 Finland

Diabetic background retinopathy

31.3

162.9

109

H35.36

ICD-10 Finland

Macular cyst

10.2

161.0

185

178

H43.1

ICD-10 Finland

Vitreous haemorrhage

5.2

149.2

321

619

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

5.2

148.5

317

607

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.1

147.8

1848

9720

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

3.6

146.6

520

1468

S01EE04

ATC

travoprost; ophthalmic

7.0

142.4

223

315

H25.8

ICD-10 Finland

Other senile cataract

2.0

139.7

1770

9332

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

659.6

135.2

135

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

14.3

133.4

124

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

5.4

132.9

269

491

H40.0

ICD-10 Finland

Glaucoma suspect

2.8

130.4

726

2669

H35.9

ICD-10 Finland

Retinal disorder, unspecified

11.9

129.5

134

110

S01EX03, ,

ATC

6.7

128.7

210

310

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

7.7

125.6

180

230

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

6.1

125.5

222

356

ZXA05

NOMESCO Finland

Left side

1.8

124.9

2598

16046

CHD00

NOMESCO Finland

Laser trabeculoplasty

15.6

123.3

109

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

599.9

122.8

123

S01EC03

ATC

dorzolamide; ophthalmic

9.5

122.2

148

153

CK2Z4

NOMESCO Finland

Ocular fundus light imaging (OCT), angiography

47.3

121.1

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

12.5

118.6

119

H35.8

ICD-10 Finland

Other specified retinal disorders

11.4

118.5

126

108

CS494

NOMESCO Finland

Other visual field testing

5.2

118.0

250

475

H3600, E113,

ICD-10 Finland

+∞

116.3

113

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.2

114.0

315

744

N02BE01

ATC

paracetamol; systemic, rectal

2.2

110.5

7486

63866

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

109.4

1203

5968

XCH05

NOMESCO Finland

Eye pressure longterm registration

12.6

105.4

105

ZXA00

NOMESCO Finland

Right side

1.7

103.2

2694

17551

H44.0

ICD-10 Finland

Purulent endophthalmitis

26.9

102.5

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

27.9

99.4

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

11.4

97.9

104

F38

ICPC

Eye, Other laboratory test NEC

4.7

95.4

224

465

S01BC03

ATC

diclofenac; ophthalmic

4.0

93.1

278

695

ZYC01

NOMESCO Finland

Remote contact by phone

2.7

86.6

505

1892

CKA10

NOMESCO Finland

Biopsy of vitreous body

21.4

86.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

82.5

6229

51477

1LA01, ,

NOMESCO Finland

+∞

82.3

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

81.3

CKC15

NOMESCO Finland

Panretinal photocoagulation

10.3

80.1

H3603, E113,

ICD-10 Finland

+∞

79.2

J01DB01

ATC

cefalexin; oral

1.6

75.6

6385

53496

Z3231

NOMESCO Finland

Registered nurse

1.6

75.3

2399

16171

S01BC05

ATC

ketorolac; ophthalmic

2.4

70.9

532

2241

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

70.0

4905

39033

H25.0

ICD-10 Finland

Senile incipient cataract

2.0

68.6

776

3853

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

317.9

64.6

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.0

62.6

285

933

S01ED02

ATC

betaxolol; ophthalmic

7.4

62.2

119

S18

ICPC

Laceration/cut

1.5

61.9

3978

30786

H54.1

ICD-10 Finland

Severe visual impairment, binocular

15.2

61.4

H40

ICD-10 Finland

Glaucoma

6.4

61.2

103

157

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.7

61.1

196

515

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

200.6

59.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

58.4

4445

35362

C08CA01

ATC

amlodipine; oral

1.5

58.3

3968

30912

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

7.1

57.6

121

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

57.0

2038

13942

CHC05

NOMESCO Finland

Iridotomy

4.8

56.9

129

260

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

190.8

56.2

1LA04, ,

NOMESCO Finland

100.3

56.0

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

55.2

2077

14349

SPAT1263

SPAT

Sampling

1.4

54.7

3415

26070

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.6

53.9

184

505

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

522.0

53.8

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.7

52.7

286

1030

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

17.0

51.9

CKD40

NOMESCO Finland

Endophotocoagulation of retina

4.2

51.4

139

323

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

3.7

50.9

165

437

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

50.4

4445

35899

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

49.8

3455

26735

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

6.0

49.5

142

S01EA03

ATC

apraclonidine; ophthalmic

5.1

49.2

105

201

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

48.9

2114

14963

T90

ICPC

Diabetes non-insulin dependent

1.5

48.8

2170

15447

SPAT1325

SPAT

Vaccination

1.4

47.2

3233

24890

L28

ICPC

Limited function/disability (L)

1.5

46.0

2205

15895

SPAT1301

SPAT

No procedures

1.4

45.8

2848

21527

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.7

45.2

106

220

S01EB01

ATC

pilocarpine; ophthalmic

7.5

44.1

A02BC02

ATC

pantoprazole; systemic

1.4

44.1

5564

47225

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

44.0

2957

22610

H35.37

ICD-10 Finland

Macular holes

3.4

43.9

162

468

Z71.8

ICD-10 Finland

Other specified counselling

1.4

43.5

2288

16744

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

5.9

42.7

126

WZC30

NOMESCO Finland

Teaching

1.6

42.5

1258

8187

H44.1

ICD-10 Finland

Other endophthalmitis

13.4

41.5

H3601, E103,

ICD-10 Finland

+∞

41.1

H81

ICPC

Excessive ear wax

1.5

39.3

1769

12536

H35.3

ICD-10 Finland

Degeneration of macula and posterior pole

15.4

39.2

H3603, E103,

ICD-10 Finland

+∞

39.1

F05

ICPC

Visual disturbance other

2.3

39.0

307

1318

AA1AD

NOMESCO Finland

CT of head and brain

1.4

38.7

2932

22740

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

38.2

2060

15078

H16.0

ICD-10 Finland

Corneal ulcer

2.3

38.1

306

1325

H35

ICD-10 Finland

Other retinal disorders

9.7

38.0

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

38.0

3879

31478

H54.5

ICD-10 Finland

Severe visual impairment, monocular

5.5

37.9

131

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

5.9

37.9

111

WX142

NOMESCO Finland

Sub-tenon anesthesy

5.1

37.6

153

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

8.6

37.2

SPAT1312

SPAT

General health counselling

1.4

36.6

2296

17229

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

36.3

3298

26231

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.1

36.1

233

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

36.1

604

3386

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

36.0

2480

18883

H3601, E116,

ICD-10 Finland

+∞

36.0

M79.6

ICD-10 Finland

Pain in limb

1.3

35.9

3167

25069

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

35.6

531

2875

R42

ICD-10 Finland

Dizziness and giddiness

1.4

35.2

2259

16990

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.8

35.0

159

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

35.0

2550

19573

CS2P4

NOMESCO Finland

Optic nerve head imaging

5.5

34.9

120

R03AC02

ATC

salbutamol; inhalant

1.3

34.0

3766

30744

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

33.7

2408

18403

H13

ICPC

Plugged feeling ear

1.4

33.4

1839

13459

J01CA04

ATC

amoxicillin; systemic

1.4

33.2

5790

50363

EBA00

NOMESCO Finland

Extraction of tooth

1.4

33.2

2336

17803

WX002

NOMESCO Finland

Sedation and analgesia

1.4

32.8

1605

11502

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.3

32.6

240

1001

T89

ICPC

Diabetes insulin dependent

2.6

32.4

184

679

C10AA01

ATC

simvastatin; oral

1.3

32.4

4402

36877

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

32.4

294

1338

M54.5

ICD-10 Finland

Low back pain

1.4

32.0

2432

18735

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

31.9

2782

21875

F28

ICPC

Limited function/disability (F)

3.9

31.5

227

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

31.5

1669

12120

A28

ICPC

Limited function/disability NOS

1.4

31.2

2313

17738

H91.1

ICD-10 Finland

Presbycusis

1.5

31.1

937

6090

H54.4

ICD-10 Finland

Blindness, monocular

6.9

31.0

1LA0P, ,

NOMESCO Finland

+∞

30.8

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

30.8

K02.1

ICD-10 Finland

Caries of dentine

1.3

30.6

3307

26765

CHD35

NOMESCO Finland

Laser goniopuncture

302.6

30.4

B01AF02

ATC

apixaban; oral

1.4

30.3

1559

11252

SPAT1262

SPAT

Handing over of treatment supplies

1.4

30.0

1465

10476

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

29.9

2406

18655

C10AA05

ATC

atorvastatin; oral

1.3

29.7

3812

31531

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

29.5

1820

13538

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

292.4

29.4

UJF32

NOMESCO Finland

Coloscopy

1.3

29.3

2271

17494

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

149.9

29.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

28.8

1705

12591

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

28.6

2224

17134

SPAT1153

SPAT

Removal of sutures

1.3

28.5

2547

20019

SPAT1310

SPAT

Counselling related to known health issue

1.3

28.5

2359

18340

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.3

28.5

110

328

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

282.3

28.4

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

28.3

1048

7107

R06.0

ICD-10 Finland

Dyspnoea

1.3

28.2

2452

19187

H35.1

ICD-10 Finland

Retinopathy of prematurity

42.3

28.1

ZXE00

NOMESCO Finland

One hour or less

1.3

28.1

2810

22424

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

28.1

2075

15855

L03

ICPC

Low back symptom/complaint

1.4

27.9

1969

14934

H3600, E103,

ICD-10 Finland

+∞

27.7

H3602, E113,

ICD-10 Finland

+∞

27.7

A10AB05

ATC

insulin aspart; parenteral

1.7

27.7

552

3245

F93

ICPC

Glaucoma

7.0

27.4

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

27.4

1637

12092

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

27.3

486

2769

SFA10

NOMESCO Finland

One-surface restoration

1.3

27.2

3198

26044

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.1

26.9

179

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

7.7

26.8

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

26.8

2655

21126

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

26.7

3311

27132

E0000UV, ,

ATC

1.3

26.7

3007

24340

SPAT1216

SPAT

Assessment of functional ability

1.4

26.5

1731

12957

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

26.5

1635

12133

H54.7

ICD-10 Finland

Unspecified visual loss

3.9

26.3

195

CKD15

NOMESCO Finland

Injection of vitreous substitute

5.4

25.9

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

25.7

2754

22111

C07AB07

ATC

bisoprolol; oral

1.3

25.7

4759

40937

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

25.5

511

3006

SPAT1254

SPAT

Administration of medicine

1.4

25.4

1480

10874

CHD99

NOMESCO Finland

Other filtering operation

251.9

25.3

C03CA01

ATC

furosemide; systemic

1.3

25.3

3800

31829

H02AB06

ATC

prednisolone; systemic

1.3

25.3

3722

31098

Z5132

NOMESCO Finland

Nursing associate professional

4.3

25.1

143

SFA20

NOMESCO Finland

Two-surface restoration

1.3

24.9

3155

25856

A04

ICPC

Weakness/tiredness general

1.4

24.7

1433

10513

H40.8

ICD-10 Finland

Other glaucoma

34.4

24.7

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

24.7

D07AC01

ATC

betamethasone; topical

1.3

24.7

2611

20905

A10AE04

ATC

insulin glargine; parenteral

1.5

24.4

713

4593

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.5

24.4

807

5339

R53

ICD-10 Finland

Malaise and fatigue

1.3

24.4

2132

16630

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

24.1

2449

19492

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

23.5

23.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

23.8

3000

24532

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

23.7

2219

17461

R06AE07

ATC

cetirizine; oral

1.3

23.7

2744

22199

R02

ICPC

Shortness of breath/dyspnoea

1.4

23.4

1204

8652

C09CA01

ATC

losartan; oral

1.3

23.1

2279

18045

Z01.2

ICD-10 Finland

Dental examination

1.3

23.0

2559

20575

XKD00

NOMESCO Finland

Uroflowmetry

1.4

23.0

1433

10621

J01MA02

ATC

ciprofloxacin; systemic

1.3

23.0

3226

26690

H20.1

ICD-10 Finland

Chronic iridocyclitis

4.1

22.9

149

H27.1

ICD-10 Finland

Dislocation of lens

4.1

22.9

145

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

22.9

2061

16116

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

32.2

22.9

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

22.8

2253

17836

L17

ICPC

Foot/toe symptom/complaint

1.3

22.6

2295

18225

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

52.2

22.6

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

22.5

667

4308

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

35.1

22.5

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

22.5

1773

13607

-1, ,

NOMESCO Finland

1.3

22.4

1745

13367

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

22.1

785

5265

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

21.9

1289

9460

H02

ICPC

Hearing complaint

1.3

21.8

1448

10829

S97

ICPC

Chronic ulcer skin

1.5

21.6

628

4040

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

21.4

2580

20907

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

21.3

1175

8531

A10AE06

ATC

insulin degludec; parenteral

2.2

21.2

175

768

C08CA13

ATC

lercanidipine; oral

1.4

21.2

1381

10295

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

21.1

1195

8711

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.6

21.0

458

2755

H44.2

ICD-10 Finland

Degenerative myopia

8.2

20.9

G04BD12

ATC

mirabegron; oral

1.4

20.7

1179

8602

CKC20

NOMESCO Finland

Cryopexy of undetached retina

7.4

20.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

20.4

2427

19614

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

20.4

1040

7452

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

20.3

1293

9597

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

20.3

2420

19560

H3601, E117,

ICD-10 Finland

202.9

20.3

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.6

20.1

173

A10BA02

ATC

metformin; oral

1.3

20.1

2398

19374

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

20.0

754

5113

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

19.9

1334

9976

G04CA02

ATC

tamsulosin; oral

1.3

19.8

2193

17554

J01AA02

ATC

doxycycline; systemic

1.3

19.7

5804

51825

C10AA07

ATC

rosuvastatin; oral

1.3

19.7

2325

18751

H3601, E119,

ICD-10 Finland

+∞

19.5

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

19.5

2254

18131

F29

ICPC

Eye symptom/complaint other

1.5

19.5

672

4479

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

19.3

3182

26653

H57.1

ICD-10 Finland

Ocular pain

2.1

19.1

188

885

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

19.1

370

2159

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.3

19.0

SPAT1097

SPAT

Recording of ECG

1.3

18.9

1270

9495

SDA03

NOMESCO Finland

Periodontal treatment

1.3

18.9

2042

16279

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

18.7

561

3631

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

18.7

906

6431

R5110, ,

SPAT

1.4

18.6

835

5845

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

18.6

2967

24737

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

18.5

585

3831

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

18.5

154

680

R01AD09

ATC

mometasone; nasal

1.3

18.4

2477

20251

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

18.2

1256

9426

B01AC04

ATC

clopidogrel; oral

1.3

18.2

1674

13070

R95

ICPC

Chron obstructive pulmonary disease

1.8

18.1

277

1511

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

18.1

696

4737

WW200, ,

SPAT

1.3

18.1

1993

15913

CD2S4

NOMESCO Finland

Photography of eye

3.6

18.1

154

H35.4

ICD-10 Finland

Peripheral retinal degeneration

3.4

17.9

187

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

17.8

1406

10747

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.0

17.8

202

1002

A10AE05

ATC

insulin detemir; parenteral

1.7

17.7

335

1943

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

17.6

431

2666

KMAK, ,

NOMESCO Finland

1.2

17.6

2762

22947

A10BK03

ATC

empagliflozin; oral

1.4

17.6

749

5195

N30.0

ICD-10 Finland

Acute cystitis

1.3

17.3

1429

10989

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

17.3

1159

8656

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

17.2

717

4954

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

5.0

17.2

D07AC13

ATC

mometasone; topical

1.3

17.1

1917

15317

ZXD20

NOMESCO Finland

Day surgery

1.4

17.1

815

5763

K85

ICPC

Elevated blood pressure

1.3

17.1

1538

11960

CFW99

NOMESCO Finland

Other operation on conjunctiva

27.8

17.1

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.6

17.1

233

3930

N03AX12

ATC

[U] gabapentin; oral

1.3

17.0

1118

8320

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

16.8

2388

19607

SPAT1260

SPAT

Consultation of another employee

1.3

16.7

1337

10234

A10AA01, ,

ATC

2.7

16.7

304

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

16.7

2076

16787

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

16.7

917

6640

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

2.5

16.7

106

416

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.8

16.6

250

1358

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

16.4

2130

17300

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

16.4

1950

15683

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

16.4

868

6248

R05

ICPC

Cough

1.3

16.4

1631

12841

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

16.3

1093

8155

M01AH05

ATC

etoricoxib; oral

1.2

16.3

3655

31424

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

16.3

5998

54165

N03AX16

ATC

[U] pregabalin

1.3

16.3

1656

13070

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

16.2

2077

16838

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

5.2

16.2

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

16.2

970

7116

S29

ICPC

Skin symptom/complaint other

1.3

16.2

1518

11856

C09AA05

ATC

ramipril; oral

1.2

16.2

2428

20031

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.2

16.1

133

585

A10AB04

ATC

insulin lispro; parenteral

2.3

16.1

115

476

H61.2

ICD-10 Finland

Impacted cerumen

1.5

15.9

558

3728

N06AX11

ATC

mirtazapine; oral

1.2

15.9

2441

20177

A10BH05

ATC

linagliptin; oral

1.5

15.9

521

3435

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.5

15.8

554

3704

H01.0

ICD-10 Finland

Blepharitis

1.6

15.8

326

1935

G04CB01

ATC

finasteride; oral

1.3

15.6

1118

8418

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

3.6

15.6

133

DAX08

NOMESCO Finland

Fitting of hearing aid

1.4

15.6

603

4108

SPAT1043

SPAT

Audiometry

1.3

15.5

970

7160

Z2221

NOMESCO Finland

Medical doctor

1.3

15.5

1862

14973

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

15.5

1536

12072

UKC02

NOMESCO Finland

Cystoscopy

1.3

15.5

1494

11702

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

15.5

1147

8679

CKD60

NOMESCO Finland

Anterior vitrectomy

2.5

15.4

368

WX199

NOMESCO Finland

Other local analgesia

1.7

15.4

296

1725

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

15.4

1873

15086

SFA30

NOMESCO Finland

Three-surface restoration

1.2

15.4

2319

19122

SPAT1009

SPAT

Measurement of intraocular pressure

2.5

15.3

386

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

15.3

813

5851

WZC00, ,

SPAT

1.4

15.3

892

6515

R4110, ,

SPAT

1.3

15.3

945

6964

R03BB04

ATC

tiotropium bromide; inhalant

1.4

15.3

915

6710

L13

ICPC

Hip symptom/complaint

1.3

15.3

1574

12428

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.1

15.3

192

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

15.2

1949

15782

N17

ICPC

Vertigo/dizziness

1.3

15.1

1157

8791

M48.0

ICD-10 Finland

Spinal stenosis

1.3

15.1

1175

8951

OAB50, ,

SPAT

1.5

15.1

544

3657

R05

ICD-10 Finland

Cough

1.3

15.0

1448

11338

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

15.0

555

3747

207

Kela drug reimbursment

Chronic arrhythmias

1.3

14.9

1809

14554

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

14.9

862

6291

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

17.1

14.8

H33.2

ICD-10 Finland

Serous retinal detachment

5.1

14.8

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

14.8

773

5550

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

14.7

956

7096

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

14.7

1476

11612

WX290

NOMESCO Finland

Other blockage of nerve

1.2

14.7

2004

16335

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

14.7

1070

8076

M03BX02

ATC

tizanidine; oral

1.2

14.6

3470

29888

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

3.6

14.4

122

H40.12

ICD-10 Finland

Pigmentary glaucoma

77.3

14.3

H3601, E118,

ICD-10 Finland

144.8

14.2

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

14.2

1999

16335

SPAT1234

SPAT

Support of social functional capacity

1.4

14.2

573

3932

RS226, ,

NOMESCO Finland

34.8

14.2

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

14.2

370

2325

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

14.1

1530

12142

A02BC05

ATC

esomeprazole; systemic

1.2

14.1

2855

24200

F84

ICPC

Macular degeneration

26.2

14.0

R96

ICPC

Asthma

1.4

13.9

675

4783

B01AB05

ATC

enoxaparin; parenteral

1.2

13.9

2558

21471

A10AB01

ATC

insulin (human); parenteral

2.0

13.8

140

669

S21

ICPC

Skin texture symptom/complaint

1.3

13.8

1129

8652

SPAT1229

SPAT

Assessment of need for aid

1.4

13.7

763

5529

R60.0

ICD-10 Finland

Localized oedema

1.3

13.7

1156

8892

H20.8

ICD-10 Finland

Other iridocyclitis

4.6

13.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

13.7

4144

36405

N06AX21

ATC

duloxetine; oral

1.4

13.7

659

4667

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

13.7

773

5618

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

13.6

1476

11708

H30.2

ICD-10 Finland

Posterior cyclitis

5.8

13.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

13.5

945

7085

J01FA10

ATC

azithromycin; systemic

1.2

13.5

3065

26225

C08CA02

ATC

felodipine; oral

1.3

13.5

963

7240

SPAT1053

SPAT

Memory test

1.2

13.5

1725

13942

R03DC03

ATC

montelukast; oral

1.3

13.4

871

6460

A01

ICPC

Pain general/multiple sites

1.4

13.4

792

5793

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

72.5

13.4

K02.2

ICD-10 Finland

Caries of cementum

1.6

13.2

342

2144

SPAT1211

SPAT

Application of soft bandage

1.4

13.2

665

4743

C09CA06

ATC

candesartan; oral

1.2

13.2

1640

13212

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

13.2

2095

17319

C09DA06

ATC

candesartan and diuretics; oral

1.4

13.1

553

3828

G04CB02

ATC

dutasteride; oral

1.4

13.0

686

4927

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

13.0

1339

10553

Z2446

NOMESCO Finland

Social worker

1.5

13.0

390

2526

RS222, ,

NOMESCO Finland

2.2

12.9

102

442

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

12.8

1272

9980

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

12.8

620

4395

-44

ICPC

Preventive immunization/medic

1.4

12.8

701

5069

H26.2

ICD-10 Finland

Complicated cataract

2.6

12.8

279

D82

ICPC

Teeth/gum disease

1.2

12.8

1762

14348

L57.0

ICD-10 Finland

Actinic keratosis

1.3

12.7

1149

8908

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

12.7

473

3198

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

6.1

12.6

K86

ICPC

Hypertension uncomplicated

1.3

12.6

1211

9465

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

12.6

878

6580

H21.0

ICD-10 Finland

Hyphaema

4.2

12.6

Z00.0

ICD-10 Finland

General medical examination

1.3

12.5

1369

10860

H04AA01

ATC

glucagon; nasal, parenteral

3.0

12.5

179

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.7

12.5

250

1475

F99

ICPC

Eye/adnexa disease other

2.7

12.4

227

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.1

12.4

119

557

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

12.4

2615

22180

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

67.4

12.4

CKC99

NOMESCO Finland

Other extraocular operations on vitreous body and retina

30.9

12.3

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.3

12.3

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

12.3

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

125.5

12.2

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.8

12.2

174

932

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

12.2

918

6950

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

12.2

1414

11294

S01EA02

ATC

dipivefrine; ophthalmic

8.9

12.1

A10BK01

ATC

dapagliflozin; oral

1.4

12.1

537

3752

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

12.0

1419

11352

S04

ICPC

Lump/swelling localized

1.4

12.0

666

4823

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.3

11.9

870

6558

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

11.9

778

5774

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

11.9

2545

21598

A29

ICPC

General symptom/complaint other

1.3

11.8

1132

8835

UDC00

NOMESCO Finland

Ear microscopy

1.4

11.8

503

3485

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

11.8

934

7120

A10BH01

ATC

sitagliptin; oral

1.3

11.7

743

5491

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

4.2

11.7

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.6

1072

8330

U02

ICPC

Urinary frequency/urgency

1.3

11.6

1132

8855

L01

ICPC

Neck symptom/complaint

1.3

11.6

923

7038

A99

ICPC

Disease/condition unspecnature/site

1.3

11.6

776

5780

J05AB01

ATC

aciclovir; systemic

1.2

11.5

1418

11390

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.6

11.4

232

C10AX09

ATC

ezetimibe; oral

1.3

11.4

1156

9083

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

62.7

11.4

M01AB05

ATC

diclofenac; systemic, rectal

1.2

11.4

4246

37711

H3601, E1100,

ICD-10 Finland

+∞

11.3

H3601, H547,

ICD-10 Finland

+∞

11.3

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

11.3

787

5894

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.0

11.3

M25.5

ICD-10 Finland

Pain in joint

1.2

11.3

1785

14715

CKD20

NOMESCO Finland

Removal of vitreous body substitute

3.4

11.2

110

R33

ICD-10 Finland

Retention of urine

1.3

11.2

758

5653

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

11.2

358

2351

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

11.2

243

1464

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

11.1

574

4110

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

11.1

389

2602

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

11.1

1113

8736

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.4

11.1

452

3111

A08

ICPC

Swelling

1.4

11.1

528

3733

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

11.0

1485

12037

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

11.0

1399

11274

B01AF03

ATC

edoxaban; oral

1.6

11.0

240

1448

A10AC01

ATC

insulin (human); parenteral

1.4

11.0

480

3344

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

11.0

909

6967

R01AD12

ATC

fluticasone furoate; nasal

1.2

10.9

1299

10394

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

10.9

654

4795

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

10.9

1007

7827

H84

ICPC

Presbyacusis

1.4

10.8

451

3117

C01DA14

ATC

isosorbide mononitrate; oral

1.2

10.8

1905

15861

H54.0

ICD-10 Finland

Blindness, binocular

5.7

10.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

10.7

2413

20525

CKD50

NOMESCO Finland

Endodiathermy of retina

8.2

10.7

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

10.7

775

5836

TDA90, ,

SPAT

1.4

10.7

520

3690

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

10.6

1667

13719

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.0

10.6

154

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

10.6

1289

10334

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

10.6

349

2307

Z46.2

ICD-10 Finland

Fitting and adjustment of other devices related to nervous system and special senses

14.9

10.6

A03

ICPC

Fever

1.3

10.6

753

5656

R01AD08

ATC

fluticasone; nasal

1.2

10.5

1470

11956

R5120

NOMESCO Finland

Preparation of an aid

1.6

10.5

266

1663

G04CA01

ATC

alfuzosin; oral

1.3

10.5

941

7286

L14

ICPC

Leg/thigh symptom/complaint

1.3

10.4

609

4445

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.7

10.4

185

1059

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

10.4

303

1954

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

10.3

1510

12338

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

10.3

1585

13014

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

10.3

869

6675

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

10.3

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

10.3

Z00.8

ICD-10 Finland

Other general examinations

1.4

10.2

487

3442

H40.1

ICD-10 Finland

Primary open-angle glaucoma

9.7

10.2

D07AD01

ATC

clobetasol; topical

1.3

10.2

1035

8128

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.5

10.2

288

1846

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

10.2

806

6142

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.4

10.1

253

M79.1

ICD-10 Finland

Myalgia

1.3

10.1

797

6070

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

10.1

710

5325

M15

ICD-10 Finland

Polyarthrosis

1.4

10.1

444

3099

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.5

10.0

263

1657

N02BF01

ATC

gabapentin; oral

1.3

10.0

624

4599

N02AX02

ATC

tramadol; systemic, rectal

1.2

10.0

3145

27457

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

10.0

535

3854

U01

ICPC

Dysuria/painful urination

1.4

10.0

549

3972

R51.80

ICD-10 Finland

Headache

1.3

10.0

773

5872

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

9.9

981

7683

I50

ICD-10 Finland

Heart failure

1.4

9.8

387

2647

SPAT1058

SPAT

PEF monitoring instruction

1.4

9.8

539

3902

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.3

9.7

739

5598

WX320

NOMESCO Finland

Spinalanesthesy

1.2

9.7

1853

15513

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

9.7

1102

8765

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.6

9.6

211

1277

U07

ICPC

Urine symptom/complaint other

1.3

9.6

674

5053

SPAT1014

SPAT

Treatment of eyes

1.7

9.6

159

894

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.4

9.6

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

9.5

484

3457

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

9.5

654

4886

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.4

9.5

260

K78

ICPC

Atrial fibrillation/flutter

1.3

9.5

846

6539

M01AE02

ATC

naproxen; oral, rectal

1.2

9.5

3396

29902

A46

ICD-10 Finland

Erysipelas

1.2

9.5

1218

9814

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

53.1

9.5

R04.0

ICD-10 Finland

Epistaxis

1.3

9.5

663

4968

R31

ICD-10 Finland

Unspecified haematuria

1.3

9.4

893

6954

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

9.4

430

3019

TQW80

NOMESCO Finland

Local dermatologic skincare

1.7

9.4

184

1082

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

9.4

1316

10700

AN1

Coronary angiography

1.2

9.3

1063

8454

H53.8

ICD-10 Finland

Other visual disturbances

2.1

9.3

386

N05BA04

ATC

oxazepam; oral

1.2

9.3

1900

15996

R06AX27

ATC

desloratadine; oral

1.2

9.3

1201

9682

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

9.3

677

5102

H3601, E106,

ICD-10 Finland

+∞

9.2

3625B

ICD-9 Finland

Other retinal disorders, Degeneration of macula and posterior pole[DEGENERATIO MACULAE EXSUDATIVA]

+∞

9.2

H3601, H350,

ICD-10 Finland

+∞

9.2

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

9.2

1298

10554

RS221, ,

NOMESCO Finland

2.1

9.2

369

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.5

9.2

269

1738

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

9.2

162

D11

ICPC

Diarrhoea

1.3

9.2

590

4370

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

9.2

981

7750

L15

ICPC

Knee symptom/complaint

1.2

9.1

1655

13787

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.8

9.1

152

DFF15

NOMESCO Finland

Speech audiometry

1.4

9.1

435

3081

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

9.0

471

3379

A11

ICPC

Chest pain NOS

1.3

9.0

666

5025

J45

ICD-10 Finland

Asthma

1.3

9.0

582

4311

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.4

9.0

492

3555

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

9.0

683

5172

S22.3

ICD-10 Finland

Fracture of rib

1.4

9.0

495

3585

H29

ICPC

Ear symptom/complaint other

1.3

8.9

893

6997

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

8.9

1189

9611

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.2

8.9

994

7884

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

8.9

712

5428

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.6

8.9

177

1046

R55

ICD-10 Finland

Syncope and collapse

1.2

8.9

1002

7963

S76

ICPC

Skin infection other

1.4

8.8

363

2503

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.7

8.8

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

8.8

716

5472

D07AB08

ATC

desonide; topical

1.3

8.8

682

5180

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

8.8

387

2701

EB1VA, ,

NOMESCO Finland

1.3

8.8

783

6053

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.8

3331

29406

C09DA01

ATC

losartan and diuretics; oral

1.3

8.7

830

6465

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

1.5

8.7

263

1710

M01AC06

ATC

meloxicam; systemic, rectal

1.2

8.7

2378

20480

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

2.0

8.7

449

H02.1

ICD-10 Finland

Ectropion of eyelid

1.8

8.7

126

682

S01KA02

ATC

hypromellose; ophthalmic

1.8

8.7

136

753

P20

ICPC

Memory disturbance

1.2

8.7

1679

14061

RK322, ,

NOMESCO Finland

7.2

8.6

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.3

8.6

671

5100

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

3.7

8.6

L12

ICPC

Hand/finger symptom/complaint

1.2

8.6

990

7886

H33.5

ICD-10 Finland

Other retinal detachments

2.5

8.5

208

RK321, ,

NOMESCO Finland

8.3

8.5

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

9.1

8.5

JN4AD

NOMESCO Finland

Body CT examination

1.3

8.5

877

6896

A10AA02, ,

ATC

1.7

8.5

142

801

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

8.5

337

2310

SFA00

NOMESCO Finland

Small restoration

1.3

8.5

701

5368

I95.1

ICD-10 Finland

Orthostatic hypotension

1.4

8.4

435

3117

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

8.4

2718

23692

K29

ICPC

Cardiovascular sympt/complt other

1.4

8.4

383

2689

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

8.4

386

2714

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

8.4

724

5573

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.3

8.4

596

4476

H31.4

ICD-10 Finland

Choroidal detachment

15.7

8.4

J01MA12

ATC

levofloxacin; systemic

1.2

8.3

1428

11822

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

8.3

467

3389

R1250, ,

SPAT

1.6

8.3

208

1299

J01CF05

ATC

flucloxacillin; systemic

1.4

8.3

389

2744

CB9S4

NOMESCO Finland

Photography of eyelids and eyebrows

3.3

8.3

K08.3

ICD-10 Finland

Retained dental root

1.3

8.3

515

3794

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

8.3

406

2885

F94

ICPC

Blindness

9.7

8.3

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

6.7

8.3

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

1.8

8.3

125

686

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

8.2

324

2218

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

8.2

1802

15239

R4135

NOMESCO Finland

Rehabilitation for hearing problems

1.6

8.2

194

1196

J01CA08

ATC

pivmecillinam; oral

1.2

8.2

2888

25318

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.3

8.2

512

3775

H3602, E103,

ICD-10 Finland

+∞

8.2

Z29

ICPC

Social problem NOS

1.7

8.2

144

824

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.3

8.2

583

4378

L08

ICPC

Shoulder symptom/complaint

1.2

8.2

1454

12075

S82

ICPC

Naevus/mole

1.3

8.2

831

6522

R74

ICPC

Upper respiratory infection acute

1.2

8.2

1191

9709

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

8.1

331

2280

U05

ICPC

Urination problems other

1.3

8.1

455

3302

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.4

8.1

225

ZXD05

NOMESCO Finland

Urgent procedure

1.2

8.1

2059

17618

G47.3

ICD-10 Finland

Sleep apnoea

1.2

8.1

1122

9103

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.7

8.1

153

894

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

9.1

8.0

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

3.9

8.0

S06.0

ICD-10 Finland

Concussion

1.3

8.0

721

5580

M02AA07

ATC

piroxicam; topical

1.2

8.0

2801

24538

R03BA08

ATC

ciclesonide; inhalant

1.3

8.0

449

3261

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

8.0

1260

10352

S01BA01

ATC

dexamethasone; ophthalmic

1.5

8.0

203

1274

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

1.8

8.0

121

665

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.4

8.0

345

2404

S10

ICPC

Boil/carbuncle

1.4

8.0

322

2217

R52.2

ICD-10 Finland

Other chronic pain

1.5

7.9

214

1360

RK320, ,

NOMESCO Finland

2.1

7.9

314

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

3.7

7.9

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.3

7.9

252

J02AC01

ATC

fluconazole; systemic

1.2

7.9

2043

17501

GD1AA, ,

SPAT

1.3

7.9

540

4035

K05.30

ICD-10 Finland

Periodontitis complex

1.2

7.9

870

6892

SPAT1281

SPAT

Other administrative function

1.3

7.9

497

3671

C02AC05

ATC

moxonidine; oral

1.4

7.9

364

2564

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

7.8

273

1829

C09CA03

ATC

valsartan; oral

1.3

7.8

716

5554

R3120

NOMESCO Finland

Training in mobility skills

3.1

7.8

101

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.4

7.8

319

2202

H34.1

ICD-10 Finland

Central retinal artery occlusion

2.3

7.8

242

M01AX05

ATC

glucosamine; oral

1.2

7.8

1830

15561

R35

ICD-10 Finland

Polyuria

1.3

7.7

524

3910

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

1.7

7.7

145

846

OAB42, ,

SPAT

1.3

7.7

663

5103

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

7.7

728

5668

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

7.7

1594

13410

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.7

2380

20658

J01FF01

ATC

clindamycin; systemic

1.2

7.7

1655

13970

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

7.6

553

4165

H03AA01

ATC

levothyroxine sodium; systemic

1.2

7.6

1612

13583

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

7.6

2464

21451

M05BA04

ATC

alendronic acid; oral

1.2

7.6

904

7220

SCA02

NOMESCO Finland

Preventive oral health care

1.3

7.6

439

3203

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

8.1

7.6

L05

ICPC

Flank/axilla symptom/complaint

1.3

7.6

411

2972

N02BF02

ATC

pregabalin; oral

1.4

7.5

373

2657

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.0

7.5

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

6.7

7.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.3

7.5

538

4046

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.3

7.5

457

3362

B01AF01

ATC

rivaroxaban; oral

1.2

7.4

1072

8730

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.5

7.4

202

1288

M54.3

ICD-10 Finland

Sciatica

1.4

7.4

348

2459

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.5

7.4

247

1643

S01

ICPC

Pain/tenderness of skin

1.4

7.3

308

2135

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

7.3

263

1772

H01

ICPC

Ear pain/earache

1.3

7.3

550

4161

ZYC01, ,

SPAT

1.3

7.3

500

3736

R06AX22

ATC

ebastine; oral

1.2

7.3

776

6121

J01FA09

ATC

clarithromycin; systemic

1.2

7.3

1626

13754

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

7.3

1066

8690

CHC03

NOMESCO Finland

Laser iridoplasty

77.3

7.3

K30

ICD-10 Finland

Functional dyspepsia

1.3

7.3

644

4974

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.2

7.3

828

6582

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

7.2

519

3904

H02.4

ICD-10 Finland

Ptosis of eyelid

1.5

7.2

194

1233

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.2

7.2

816

6481

J01EA01

ATC

trimethoprim; systemic

1.2

7.2

2059

17751

N63

ICD-10 Finland

Unspecified lump in breast

1.4

7.2

328

2306

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

1.8

7.2

530

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.5

7.2

243

1621

D06

ICPC

Abdominal pain localized other

1.3

7.2

496

3714

H53.4

ICD-10 Finland

Visual field defects

1.6

7.1

141

835

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

7.1

112

D19

ICPC

Teeth/gum symptom/complaint

1.2

7.1

1403

11749

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.3

7.1

636

4920

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.6

7.1

154

933

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.2

7.1

1222

10115

CK2M4, ,

SPAT

15.2

7.1

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

7.1

379

2736

C03DA01

ATC

spironolactone; oral

1.2

7.1

1146

9435

N07BA03

ATC

varenicline; oral

1.7

7.0

124

712

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

1.7

7.0

120

683

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.0

601

4623

CK2X4, ,

SPAT

4.2

7.0

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

7.0

227

1501

H35.29

ICD-10 Finland

Other proliferative retinopathy

19.3

7.0

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

7.0

594

4568

I50.0

ICD-10 Finland

Congestive heart failure

1.2

7.0

907

7310

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.4

7.0

255

1726

Z72.0

ICD-10 Finland

Tobacco use

1.8

7.0

535

R39.1

ICD-10 Finland

Other difficulties with micturition

1.5

6.9

220

1449

L60.0

ICD-10 Finland

Ingrowing nail

1.4

6.9

273

1873

H25.9

ICD-10 Finland

Senile cataract, unspecified

1.6

6.9

156

954

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

1.6

6.9

135

797

R60.9

ICD-10 Finland

Oedema, unspecified

1.3

6.9

452

3359

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

6.9

666

5199

RD211, ,

NOMESCO Finland

1.5

6.9

239

1602

B02

ICD-10 Finland

Zoster [herpes zoster]

1.4

6.9

279

1924

K59.0

ICD-10 Finland

Constipation

1.3

6.9

468

3497

N19

ICD-10 Finland

Unspecified kidney failure

1.4

6.9

360

2590

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.2

6.9

929

7517

ZXC50

NOMESCO Finland

Cryotherapy

1.4

6.9

287

1990

ZXE90

NOMESCO Finland

More than 22 hours

2.0

6.9

313

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.3

6.9

416

3059

W19

ICD-10 Finland

Unspecified fall

1.2

6.8

758

6009

N05CF01

ATC

zopiclone; oral

1.1

6.8

2635

23182

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

6.8

645

5024

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

6.8

177

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.5

6.8

213

1401

R06AE09

ATC

levocetirizine; oral

1.3

6.8

592

4569

N18.8

ICD-10 Finland

Other chronic renal failure

1.5

6.7

203

1325

S19

ICPC

Skin injury other

1.4

6.7

267

1836

CBN20

NOMESCO Finland

Shortening of eyelid retractors

1.9

6.7

403

CA1AD

NOMESCO Finland

Orbita CT

3.9

6.7

ZXC20

NOMESCO Finland

Use of chemical agents

1.6

6.7

151

925

WZC30, ,

SPAT

1.3

6.7

494

3734

SPAT1101

SPAT

Orthostatic test

1.3

6.7

444

3309

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.5

6.6

954

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

6.6

1508

12767

S01FA04

ATC

cyclopentolate; ophthalmic

2.1

6.6

278

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

6.6

515

3915

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

6.6

608

4717

C09DA03

ATC

valsartan and diuretics; oral

1.4

6.6

342

2456

D01

ICPC

Abdominal pain/cramps general

1.2

6.6

657

5146

E000006, ,

ATC

1.3

6.6

423

3135

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.2

6.6

1053

8654

R52.9

ICD-10 Finland

Pain, unspecified

1.3

6.6

631

4921

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.3

6.6

462

3469

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

6.6

456

3418

D02

ICPC

Abdominal pain epigastric

1.4

6.5

342

2460

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.9

6.5

H30.8

ICD-10 Finland

Other chorioretinal inflammations

21.7

6.5

-31

ICPC

Medical examin/health eval partial

1.3

6.5

494

3744

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

3.0

6.5

S01BA07

ATC

fluorometholone; ophthalmic

1.9

6.5

373

N05AD03

ATC

melperone; systemic

0.3

6.5

617

R5599

NOMESCO Finland

Other rehabilitation service

1.5

6.5

169

1069

M75

ICD-10 Finland

Shoulder lesions

1.4

6.5

233

1573

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.4

6.5

287

2011

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.6

6.4

140

850

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

6.4

241

1640

U08

ICPC

Urinary retention

1.5

6.4

175

1118

H18.2

ICD-10 Finland

Other corneal oedema

3.3

6.4

H43.3

ICD-10 Finland

Other vitreous opacities

1.9

6.4

375

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.5

6.4

206

1362

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

6.4

557

4297

S81.7

ICD-10 Finland

Multiple open wounds of lower leg

2.7

6.4

119

L72.1

ICD-10 Finland

Trichilemmal cyst

1.3

6.4

373

2729

SPE90

NOMESCO Finland

Other partial denture

1.6

6.4

155

966

TQW40, ,

SPAT

1.3

6.4

544

4188

S22

ICPC

Nail symptom/complaint

1.3

6.3

423

3154

NHQ40

NOMESCO Finland

Amputation of toe

1.7

6.3

117

682

3708

FHL

Trabeculectomy or equivalent

67.4

6.3

H40.21

ICD-10 Finland

Intermittent glaucoma with closed ventricular angle

67.4

6.3

K08.80

ICD-10 Finland

Toothache NOS

1.4

6.3

313

2235

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

1.5

6.3

168

1069

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

6.3

283

1989

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

2.4

6.3

166

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

6.3

375

2754

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.3

6.3

338

2445

130

Kela drug reimbursment

Malignant tumour

0.8

6.2

463

5636

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.5

6.2

149

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.4

6.2

261

1812

ZX120

NOMESCO Finland

Intravenous

1.3

6.2

610

4772

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

6.2

1370

11569

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

2.3

6.2

191

N07CA01

ATC

betahistine; oral

1.3

6.2

562

4356

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

6.2

1188

9918

SPAT1059

SPAT

Spirometry at the office

1.4

6.2

320

2299

K28

ICPC

Limited function/disability (K)

1.5

6.2

198

1308

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

6.2

738

5897

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

1.8

6.2

463

R03AK08

ATC

formoterol and beclometasone; inhalant

1.4

6.2

225

1524

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.2

6.2

722

5757

H02AB02

ATC

dexamethasone; systemic

0.8

6.2

478

5788

F55

ICPC

Eye, Local injection/infiltration

+∞

6.2

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

6.2

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

+∞

6.2

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

1.7

6.1

101

571

H53

ICD-10 Finland

Visual disturbances

2.4

6.1

162

ZY010

NOMESCO Finland

Hospital outpatient

1.5

6.1

170

1092

E87.5

ICD-10 Finland

Hyperkalaemia

1.5

6.1

163

1038

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

1.8

6.1

444

R21

ICPC

Throat symptom/complaint

1.2

6.1

752

6032

F0019, G301,

ICD-10 Finland

0.3

6.1

508

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.6

6.0

145

903

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019550) Sodium [Moles/volume] in Serum or Plasma

7761

64047

3.33

189.24

29.7

26.9

139.42

139.46

mmol/l

0.68

7610

62647

(3023103) Potassium [Moles/volume] in Serum or Plasma

7764

64091

3.34

189.11

30.0

27.1

4.02

4.01

mmol/l

4.84

7601

62598

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7781

64376

3.37

187.41

32.2

29.4

89.07

85.05

umol/l

11.26

7668

63222

(3010813) Leukocytes [#/volume] in Blood

7786

64481

3.37

186.35

35.8

32.5

7.12

7.05

e9/l

1.62

7561

62379

(3035941) MCH [Entitic mass]

7784

64465

3.36

186.08

35.6

32.4

30.38

30.40

0.33

7666

63366

(3007461) Platelets [#/volume] in Blood

7784

64467

3.36

186.03

35.8

32.5

238.96

239.78

e9/l

0.50

7594

62646

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7784

64468

3.36

186.00

36.3

33.0

38.70

38.78

0.58

7660

63343

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7784

64469

3.36

185.97

35.7

32.4

92.09

92.01

0.79

7665

63371

(3026361) Erythrocytes [#/volume] in Blood

7784

64469

3.36

185.97

35.8

32.5

4.28

4.30

e12/l

1.03

7554

62354

(3000963) Hemoglobin [Mass/volume] in Blood

7784

64474

3.36

185.84

36.1

32.8

129.00

129.43

g/l

1.68

7664

63412

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7660

63019

3.04

182.28

14.0

13.4

22.48

23.34

u/l

2.84

7339

60403

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7509

61682

2.70

168.53

23.7

21.6

27.64

28.87

mg/l

2.44

6708

53499

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7154

57894

2.32

158.65

8.3

7.5

41.69

40.50

mmol/mol

20.92

6465

52412

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7121

57581

2.29

157.09

23.9

22.0

65.91

68.24

ml/min/173m2

21.10

6757

54098

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7247

59095

2.36

155.52

6.6

6.4

2.40

2.46

mmol/l

6.93

6464

52914

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7063

57341

2.20

147.10

5.7

5.4

4.30

4.37

mmol/l

5.87

6312

51458

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7046

57192

2.19

146.10

6.1

5.7

2.10

2.09

mu/l

0.24

6291

51381

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7217

59200

2.28

144.72

6.2

6.0

6.20

6.10

mmol/l

8.18

6292

52397

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6984

56717

2.13

140.96

5.6

5.3

1.47

1.46

mmol/l

0.15

6173

50461

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6698

54443

1.93

121.64

4.7

4.5

1.25

1.24

mmol/l

0.23

5836

47674

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6584

53283

1.90

120.26

8.4

8.3

82.11

83.69

u/l

1.53

6193

50038

(3031040) Bacteria [#/volume] in Urine by Automated count

6179

49111

1.81

118.57

6.5

6.0

3477.23

2201.12

e6/l

0.70

114

854

(3037467) Urinalysis macro (dipstick) panel - Urine

6119

48506

1.80

118.29

5.8

5.5

1209.96

1.87

0.47

(3013826) Glucose [Moles/volume] in Serum or Plasma

5683

44278

1.74

114.48

5.5

5.1

7.01

6.84

mmol/l

7.14

5427

42254

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6138

49214

1.76

107.70

5.1

4.7

16.60

15.82

mm/h

2.90

5588

45056

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5969

47926

1.70

98.97

4.7

4.5

15.42

15.28

pmol/l

3.82

5274

42671

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5360

41879

1.65

98.47

7.6

7.1

1.21

mmol/l

1.69

4500

35744

(3009261) Glucose [Presence] in Urine by Test strip

4888

37667

1.60

91.70

5.2

4.8

0.95

0.31

estimate

0.32

1137

7748

(3035350) Ketones [Presence] in Urine by Test strip

4857

37400

1.60

91.15

5.1

4.8

1.57

2.79

estimate

0.32

1197

8224

(3032080) INR in Blood by Coagulation assay

5106

39956

1.59

87.98

22.1

21.2

1.39

1.40

inr

0.10

4372

33828

(3021601) Nitrite [Presence] in Urine by Test strip

4782

36887

1.58

87.31

5.1

4.8

0.00

estimate

0.01

1151

7846

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4085

30493

1.57

85.21

3.7

3.5

2131.55

1976.42

ng/l

1.11

3585

26861

(3044889) 12 lead EKG panel

5673

45681

1.61

85.13

5.3

5.0

0.46

927.16

0.50

109

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4996

39452

1.55

77.83

5.7

6.2

12.05

12.63

umol/l

2.12

4728

37404

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5806

47521

1.58

76.23

29.3

27.1

14.14

14.08

2.14

5719

46821

(3013650) Neutrophils [#/volume] in Blood by Automated count

4924

38929

1.53

74.86

8.1

8.9

4.63

4.44

e9/l

4.70

4219

33126

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4153

31670

1.52

74.71

5.1

4.7

96.67

86.48

ng/l

0.15

3480

25866

(3026008) Bacteria identified in Urine by Culture

3882

29272

1.52

73.00

4.1

4.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4693

36851

1.52

72.62

2.5

2.4

93.42

93.87

pmol/l

0.25

2469

19258

(3024561) Albumin [Mass/volume] in Serum or Plasma

4679

36780

1.51

71.55

4.9

4.7

33.99

34.25

g/l

2.52

4276

33932

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4757

37577

1.51

70.62

6.9

6.4

1.21

mmol/l

1.24

4321

34236

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3922

29818

1.50

69.71

3.6

3.1

141.85

153.46

ug/l

1.74

3479

26862

(3001604) Monocytes [#/volume] in Blood

4387

34269

1.49

67.34

5.7

0.65

0.63

e9/l

2.73

3679

28506

(3013115) Eosinophils [#/volume] in Blood

4494

35303

1.49

66.88

5.9

0.21

0.20

e9/l

1.84

3847

29847

(3006315) Basophils [#/volume] in Blood

4401

34458

1.49

66.37

5.8

0.04

e9/l

1.09

3705

28715

(3021960) Folate [Moles/volume] in Serum or Plasma

3465

25905

1.49

65.42

1.9

1.8

20.27

20.15

nmol/l

0.16

2870

21625

(3019198) Lymphocytes [#/volume] in Blood

4446

34960

1.48

65.06

5.9

1.76

1.85

e9/l

2.09

3851

29799

(3020682) Albumin/Creatinine [Ratio] in Urine

3444

25785

1.49

64.17

4.3

4.0

11.14

9.10

mg/mmol

1.43

2142

15784

(3012516) Albumin [Mass/volume] in Urine

3359

25033

1.49

63.98

3.5

3.3

58.20

49.47

mg/l

1.26

2181

15918

(3021589) Normoblasts [#/volume] in Blood

3764

28803

1.47

62.13

14.1

13.0

0.00

e9/l

0.04

3079

23130

(3009508) Creatinine [Moles/volume] in Urine

3364

25185

1.48

62.03

3.5

3.3

6.38

6.64

mmol/l

3.79

2689

20598

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3141

23226

1.49

61.47

2.8

2.5

3.17

3.06

mg/l

1.24

2684

19802

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4103

32035

1.46

60.36

2.5

2.4

82.19

80.79

nmol/l

2.30

3518

27758

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3566

27111

1.47

60.21

5.3

5.0

0.13

0.95

estimate

2.51

914

6357

(3019069) Monocytes/Leukocytes in Blood

4104

32095

1.46

59.54

6.2

9.20

0.04

3785

29625

(3002030) Lymphocytes/Leukocytes in Blood

4133

32404

1.45

58.91

6.2

6.1

24.11

25.05

5.84

3856

30296

(3006504) Eosinophils/Leukocytes in Blood

4089

32020

1.45

58.50

6.1

2.83

2.78

0.78

3770

29561

(3022096) Basophils/Leukocytes in Blood

4090

32036

1.45

58.39

6.2

0.63

0.10

3771

29596

(3002582) Erythrocytes [#/volume] in Urine

3512

26738

1.46

58.21

4.1

3.8

212.34

88.41

e6/l

1.11

2753

20746

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4496

35907

1.45

57.47

3.4

3.2

53.88

57.46

u/l

1.50

4054

32368

(3018010) Neutrophils/Leukocytes in Blood

4037

31660

1.44

56.53

6.1

6.0

60.37

59.48

4.58

3816

29839

(3018095) Leukocytes [#/volume] in Urine

3753

29054

1.44

56.26

4.8

4.5

169.00

142.95

e6/l

0.61

2816

21116

(3015736) pH of Urine

3871

30157

1.44

55.98

4.4

4.2

6.33

0.05

2004

15890

(3030467) Casts [#/volume] in Urine by Automated count

3082

23185

1.44

52.87

3.8

3.7

0.45

0.53

e6/l

1.21

2365

17505

(3023368) Bacteria identified in Blood by Culture

3342

25660

1.42

50.58

4.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3108

23556

1.43

50.54

2.7

2.6

66.77

64.82

u/l

0.12

2844

21602

(3029937) Albumin [Presence] in Urine by Test strip

2878

21521

1.44

50.32

5.3

4.9

0.00

estimate

0.16

1025

6989

(3022948) Iron [Moles/volume] in Serum or Plasma

2125

15095

1.48

48.19

2.9

2.6

10.96

11.42

umol/l

2.43

1934

13770

(3041096) Erythrocytes [Presence] in Urine by Automated

2469

18152

1.44

46.43

4.5

4.4

0.34

0.45

estimate

0.14

881

6066

(3015377) Calcium [Moles/volume] in Serum or Plasma

3576

28074

1.40

46.26

3.0

3.4

2.35

2.36

mmol/l

0.97

3177

24860

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3294

25507

1.40

46.17

2.3

2.2

234.45

224.63

u/l

0.20

3081

23865

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2237

16197

1.45

45.46

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1996

14171

1.47

44.83

2.9

2.6

2.24

g/l

0.22

1789

12851

(3000850) Epithelial cells [#/volume] in Urine

2534

18839

1.42

44.37

3.1

2.9

4.94

5.44

e6/l

1.36

2290

17120

(3013512) EKG study

3471

27282

1.39

43.76

4.6

4.4

0.73

0.74

0.01

(3018418) pH of Serum or Plasma

3273

25523

1.39

43.06

4.4

4.1

7.40

0.51

2392

18590

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1875

13243

1.47

42.96

2.9

2.6

19.79

20.48

1.51

1693

12076

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3506

27700

1.38

42.36

2.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2380

17670

1.42

41.37

1.9

1.8

7127644.06

24145245.37

pmol/l

2.12

1824

14061

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4036

32776

1.36

40.23

3.1

2.9

—

estimate

—

(36304419) Bacteria [Presence] in Urine

2814

21685

1.38

38.60

3.9

3.7

15.09

78.01

estimate

0.54

147

(3019309) Folate [Moles/volume] in Red Blood Cells

2411

18290

1.38

35.80

1.8

1171.88

1156.58

nmol/l

0.33

1717

13534

(3007853) Bacteria identified in Skin by Aerobe culture

1277

8641

1.50

35.44

2.0

1.8

—

(40768804) Tissue Pathology biopsy report

3304

26360

1.34

35.35

2.4

—

(3026782) Osmolality of Urine

2206

16609

1.38

33.95

3.3

510.46

524.18

mosm/kgh2o

2.64

1910

14537

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2907

22915

1.34

33.08

6.7

6.4

4.98

4.48

ug/l

0.16

2576

20245

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1683

12272

1.40

30.91

1.9

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5400

46817

1.31

29.58

32.5

29.1

329.44

329.86

g/l

2.84

5370

46388

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1024

6854

1.50

29.56

3.6

4.0

1.22

1.23

mmol/l

2.00

839

5846

(40760892) CBC W Ordered Manual Differential panel - Blood

1702

12538

1.39

29.20

4.7

4.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1566

11376

1.40

29.19

2.0

1.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2333

18173

1.33

27.59

2.9

3.1

2.48

2.47

mmol/l

0.12

2078

16027

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1953

14842

1.35

27.25

1.8

1.7

1.60

1.64

mg/l

0.13

1560

11818

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2878

23150

1.30

26.79

2.0

1.9

1.27

1.26

mmol/l

0.14

2263

18650

(3014051) Protein [Presence] in Urine by Test strip

2366

18544

1.32

26.59

3.9

3.7

0.09

0.08

101

777

(3045414) Leukocytes [Presence] in Urine

1075

7424

1.45

26.30

2.4

2.2

0.00

0.01

estimate

1.57

194

1235

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1173

8310

1.42

24.87

4.1

4.0

—

(3025159) Blasts/Leukocytes in Blood

917

6210

1.48

24.74

4.2

4.1

0.13

0.30

1.35

251

1793

(3026493) Urate [Moles/volume] in Serum or Plasma

2350

18573

1.30

24.42

3.0

363.51

361.70

umol/l

0.32

1966

15629

(3023520) Reticulocytes [#/volume] in Blood

1278

9262

1.39

23.64

2.4

67.06

67.22

e9/l

0.06

942

6847

(3012544) pH of Venous blood

1314

9583

1.38

23.38

3.8

3.5

7.38

0.50

800

5668

(3017732) Neutrophils [#/volume] in Blood

1116

7929

1.41

23.16

3.2

3.3

5.18

4.98

e9/l

0.24

885

6446

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1774

13568

1.33

23.12

3.6

3.5

2.68

3.07

e6/l

0.75

943

6951

(3016502) Oxygen saturation in Arterial blood

1313

9597

1.38

23.01

6.5

6.4

94.52

95.14

2.38

1271

9215

(3017181) Myelocytes/Leukocytes in Blood

948

6561

1.44

22.73

4.0

3.9

0.94

0.02

285

2199

(3021440) Promyelocytes/Leukocytes in Blood

911

6260

1.45

22.69

4.1

4.0

0.11

0.10

0.08

251

1916

(40758558) Short blood count panel - Blood

2573

20734

1.28

22.65

6.5

6.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2491

20003

1.28

22.51

3.0

3.1

35.07

35.71

u/l

0.11

2325

18553

(3042936) Bacteria identified in Isolate by Culture

1467

10954

1.35

22.39

2.1

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1291

9458

1.37

22.23

3.8

3.5

5.79

5.84

kpa

0.79

1257

9218

(3002179) Metamyelocytes/Leukocytes in Blood

898

6184

1.45

22.09

3.9

0.80

0.69

0.46

275

2060

(3027945) Reticulocytes/Erythrocytes in Blood

1564

11822

1.34

21.95

2.4

2.3

1.79

0.06

1344

10303

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1894

14736

1.31

21.63

3.5

3.4

1.13

1.30

e6/l

1.32

1062

8143

(3003396) Base excess in Arterial blood by calculation

1430

10690

1.35

21.57

6.4

6.2

1.02

1.09

mmol/l

0.24

1157

8697

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1138

8206

1.39

21.54

2.7

2.5

5.59

6.27

ug/l

0.82

922

6879

(3002032) Base excess in Venous blood by calculation

1259

9236

1.37

21.43

3.9

3.5

1.76

1.92

mmol/l

0.77

1073

8060

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2301

18399

1.28

21.24

5.3

5.2

22.44

22.46

0.02

1339

10258

(1761868) Lipid panel - Serum or Plasma

1934

15153

1.30

20.84

4.1

3.9

—

(40761536) Microorganisms panel - Urine sediment

805

5494

1.46

20.71

5.0

4.8

—

(3019977) pH of Arterial blood

1430

10755

1.34

20.62

6.4

6.3

7.42

0.02

826

5950

(3044640) Blood type and Crossmatch panel - Blood

2974

24610

1.26

20.44

2.8

2.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2264

18167

1.28

20.09

5.0

4.5

0.18

0.37

0.41

273

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

900

6320

1.42

19.79

1.9

1.8

—

(3019150) Specific gravity of Urine by Refractometry

2107

16789

1.28

19.72

5.6

5.1

1.02

1.19

kg/l

0.81

1486

11457

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1427

10802

1.33

19.58

6.4

6.3

5.02

5.07

kpa

1.09

1356

10300

(3027801) Oxygen [Partial pressure] in Arterial blood

1426

10800

1.33

19.49

6.4

6.3

11.26

11.78

kpa

3.56

1353

10288

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2107

16887

1.27

18.62

5.3

4.6

321.53

397.46

ng/l

0.34

1882

15138

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1687

13153

1.30

18.55

3.8

3.6

0.85

0.86

ug/l

0.15

1259

9743

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1568

12184

1.30

17.58

1.3

1.2

1.90

1.70

u/ml

0.23

385

2773

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

828

5849

1.40

17.52

3.8

5.17

5.16

kpa

0.07

770

5502

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1462

11269

1.30

17.40

5.6

5.0

1.06

1.04

mmol/l

2.47

1331

10248

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1406

10802

1.31

17.12

3.7

3.9

244.56

251.26

u/l

1.05

1316

10121

(40768797) Stomach Pathology biopsy report

1269

9614

1.32

17.10

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

1078

7978

1.35

17.06

3.2

3.0

4.40

4.29

kpa

0.94

1046

7757

(3030981) Hyaline casts [#/volume] in Urine by Automated count

957

6959

1.37

16.97

2.8

2.6

0.59

0.53

e6/l

0.36

928

6734

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1164

8723

1.33

16.92

7.0

6.9

117.25

118.48

g/l

1.36

1139

8505

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

724

5041

1.42

16.61

3.5

3.6

2.01

2.17

mmol/l

0.49

501

3735

(3009343) pH of Capillary blood

802

5691

1.40

16.49

3.7

3.8

7.41

7.42

2.35

663

4742

(3007164) IgA [Mass/volume] in Serum or Plasma

1371

10569

1.30

16.19

1.5

2.81

2.73

g/l

0.41

768

5609

(3045424) Erythrocytes [Presence] in Urine

536

3612

1.46

14.66

2.2

0.01

0.30

estimate

0.52

156

883

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2256

18647

1.23

14.43

2.8

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1697

13622

1.25

14.20

2.8

2.7

0.82

0.81

mmol/l

2.02

1559

12570

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

921

6841

1.33

14.09

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

684

4895

1.38

13.31

1.5

—

(3019225) pH of Specimen

1096

8415

1.29

13.14

4.9

4.6

7.36

0.39

773

5888

(3008152) Bicarbonate [Moles/volume] in Arterial blood

785

5754

1.35

13.10

6.9

6.0

24.29

24.58

mmol/l

1.30

751

5490

(3048689) Calprotectin [Mass/mass] in Stool

877

6539

1.33

13.03

2.0

1.9

196.67

169.67

ug/g

0.74

653

5061

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

706

5096

1.37

13.01

4.5

3.4

23.97

24.26

mmol/l

1.72

694

5009

(3020630) Protein [Mass/volume] in Serum or Plasma

1074

8254

1.29

12.76

2.6

2.5

65.74

65.48

g/l

0.53

945

7326

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

282

1705

1.61

12.74

1.6

1.5

0.60

8.17

iu/ml

1.48

410

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

938

7084

1.31

12.71

3.7

3.4

107.12

94.82

ng/l

2.33

748

5871

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1607

12971

1.24

12.61

2.1

1.9

30.09

29.90

0.58

1561

12593

(3022145) Colonoscopy Study observation

981

7470

1.30

12.50

1.4

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

680

4935

1.36

12.10

4.2

4.1

43.67

45.67

1.32

671

4869

(3003694) ABO and Rh group [Type] in Blood

1925

15897

1.22

12.05

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1196

9384

1.27

11.99

9.6

8.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

517

3595

1.41

11.93

2.7

3.1

61.77

81.87

mg/l

0.51

433

3036

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1103

8579

1.28

11.88

3.5

3.2

252.13

260.35

ng/l

0.26

1010

7891

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

515

3589

1.41

11.73

2.7

3.1

81.22

51.33

mg/l

1.09

433

3030

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

670

4884

1.35

11.58

1.6

1.59

g/l

0.03

568

4168

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

648

4701

1.36

11.56

2.6

2.5

—

(3010421) pH of Blood

398

2654

1.47

11.52

3.7

7.41

1.14

391

2601

(3020779) Urea [Moles/volume] in Serum or Plasma

1039

8061

1.28

11.39

7.2

5.7

12.24

11.67

mmol/l

1.43

968

7587

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

729

5396

1.33

11.36

6.9

6.6

24.78

24.94

mmol/l

0.54

720

5339

(3004119) Hemoglobin [Mass/volume] in Venous blood

784

5875

1.32

11.20

3.3

3.0

125.64

126.04

g/l

0.20

761

5697

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

110

522

2.04

11.13

1.1

2.14

2.49

iu/ml

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1059

8259

1.27

11.12

2.5

9.04

10.39

umol/l

1.21

935

7181

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

437

3006

1.42

10.74

3.8

4.1

24.85

25.03

mmol/l

0.50

383

2665

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

509

3609

1.38

10.49

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

547

3926

1.37

10.45

4.4

4.6

0.84

0.85

0.46

522

3715

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

565

4079

1.36

10.40

1.8

2.48

2.34

ug/l

0.09

472

3503

(40767503) Oxygen content in Capillary blood by calculation

293

1881

1.52

10.26

2.6

2.7

15.89

15.73

0.40

285

1841

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

464

3253

1.40

10.23

2.7

3.0

4.19

7.17

ratio

0.37

292

1956

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

587

4276

1.35

10.19

4.3

4.5

1.56

1.54

0.27

565

4056

(3037522) Nuclear Ab [Titer] in Serum

961

7487

1.27

10.14

1.3

513.16

501.46

titre

0.07

234

1773

(3005719) IgG [Mass/volume] in Serum or Plasma

621

4571

1.33

10.06

2.5

2.9

11.15

10.59

g/l

1.27

571

4153

(3022621) pH of Urine by Test strip

788

5997

1.29

10.02

3.6

3.3

6.04

6.08

0.55

585

4368

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

905

7011

1.27

10.00

2.4

41.93

38.16

u/l

0.39

730

5862

(3018405) Lactate [Moles/volume] in Arterial blood

432

3004

1.41

10.00

4.4

3.5

1.46

1.42

mmol/l

0.23

423

2941

(3027273) Bicarbonate [Moles/volume] in Venous blood

617

4542

1.33

9.99

3.6

3.3

24.92

25.23

mmol/l

1.23

596

4416

(3014111) Lactate [Moles/volume] in Serum or Plasma

1039

8184

1.26

9.98

6.3

6.0

1.42

1.40

mmol/l

0.25

1005

7988

(3000991) Gas panel - Venous blood

988

7740

1.26

9.94

7.6

7.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1242

9983

1.23

9.93

1.3

46.90

40.12

iu/ml

0.43

417

3019

(3036481) Cortisol [Moles/volume] in Serum or Plasma

795

6065

1.29

9.92

2.1

2.2

379.53

394.97

nmol/l

1.10

715

5485

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

460

3245

1.39

9.79

1.2

1.3

—

(3002256) Pathology report gross observation

1199

9621

1.23

9.72

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

342

2297

1.45

9.59

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

340

2284

1.45

9.53

2.8

3.0

7.70

7.74

kpa

0.19

330

2225

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

695

5239

1.30

9.50

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

471

3356

1.37

9.44

1.9

—

(3000330) Specific gravity of Urine by Test strip

623

4634

1.32

9.38

4.1

4.2

1.02

ratio

0.73

566

4200

(3028026) IgM [Mass/volume] in Serum or Plasma

503

3633

1.36

9.25

1.9

1.49

1.40

g/l

0.21

449

3224

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

739

5636

1.29

9.24

3.2

2.9

50.98

56.91

ml/min/173m2

6.50

376

2622

(3022313) Gas panel - Capillary blood

536

3911

1.34

9.22

3.9

4.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

769

5898

1.28

9.20

8.1

7.6

1.34

1.29

0.91

762

5850

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

562

4137

1.33

9.11

2.4

2.2

7.60

7.54

g/l

0.38

484

3637

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

560

4123

1.33

9.06

2.4

2.2

3.82

3.68

g/l

0.84

484

3630

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

363

2492

1.42

9.06

1.9

1.6

39.39

38.68

u/l

0.25

305

2078

(3025941) Bacteria identified in Stool by Culture

439

3116

1.38

9.02

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

561

4135

1.33

9.01

2.4

2.2

4.22

4.17

g/l

0.46

485

3642

(4024509) Urine culture

547

4040

1.33

8.67

2.3

2.1

—

(3033658) Prothrombin time (PT) actual/Normal

2170

18572

1.17

8.60

4.4

4.2

82.07

82.18

0.06

2121

18172

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

455

3275

1.36

8.57

2.2

2.1

490.08

628.72

ug/l

0.80

439

3103

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

657

4990

1.29

8.49

1.6

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

739

5710

1.27

8.33

8.4

7.8

0.60

0.64

1.50

733

5664

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

343

2368

1.41

8.32

1.5

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

264

1738

1.48

8.26

2.4

2.2

175.08

91.86

ug/min

1.38

157

957

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

961

7668

1.23

8.16

2.0

0.20

0.19

g/l

0.55

885

7039

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

190

1169

1.58

8.13

2.0

2.1

30.83

27.13

mg/l

0.32

396

(40768443) Skin Pathology biopsy report

472

3445

1.34

8.13

1.3

1.2

—

(40761535) Cells panel - Urine sediment

831

6533

1.25

8.08

4.0

3.7

—

2.00

—

(3000012) Reticulocyte production index

238

1542

1.50

8.06

2.1

0.88

0.01

170

1077

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1151

9367

1.21

8.05

1.3

19.03

15.38

u/ml

0.61

404

3044

(3017569) Oxygen content in Arterial blood

106

558

1.84

8.05

2.2

14.88

15.66

1.66

106

558

(1616796) Gas panel - Central venous blood

296

2005

1.44

8.00

3.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

517

3840

1.32

7.89

2.5

2.3

3.02

2.97

g/l

0.42

438

3340

(40760888) Immunoglobulin light chains.free panel - Serum

344

2400

1.40

7.88

2.5

3.3

—

0.93

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

437

3170

1.35

7.85

3.2

3.0

24.68

25.00

mmol/l

0.86

427

3112

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1101

8949

1.21

7.79

5.6

5.4

35.06

34.22

1.52

667

5492

(46235355) HIV 1 and 2 tests - Meaningful Use set

672

5187

1.27

7.64

1.6

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

140

814

1.67

7.56

1.4

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

649

4997

1.27

7.53

8.3

15.57

15.66

0.45

627

4809

(3013290) Carbon dioxide [Partial pressure] in Blood

263

1766

1.45

7.47

4.1

4.3

5.06

5.01

kpa

0.36

255

1709

(3044242) Glucose [Moles/volume] in Arterial blood

102

547

1.81

7.33

1.8

2.0

8.29

8.03

mmol/l

0.25

102

547

(3049717) Cytology report of Urine Cyto stain

501

3744

1.31

7.33

2.7

2.9

—

(3012501) Base excess in Blood by calculation

262

1765

1.44

7.32

4.1

4.3

2.64

2.88

mmol/l

0.65

188

1222

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

704

5493

1.26

7.31

7.5

7.6

24.37

24.38

mmol/l

0.02

677

5298

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

440

3232

1.33

7.28

2.6

2.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

107

584

1.78

7.26

1.2

—

(3021901) Oxygen saturation in Capillary blood

294

2026

1.41

7.26

2.9

3.0

88.18

88.56

0.39

285

1969

(3027315) Oxygen [Partial pressure] in Blood

263

1778

1.44

7.22

4.1

4.3

8.24

8.26

kpa

0.08

255

1720

(3028271) Lactate [Moles/volume] in Capillary blood

209

1355

1.50

7.11

1.8

1.9

1.65

1.68

mmol/l

0.13

201

1317

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

225

1483

1.47

7.06

1.2

1.3

115.38

304.67

titre

1.95

121

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

3629

1.31

7.04

2.5

2.2

10.29

10.16

g/l

0.24

403

3084

(3047181) Lactate [Moles/volume] in Blood

349

2520

1.35

6.52

5.3

1.37

mmol/l

0.04

312

2239

(3009445) Proteinase 3 Ab [Units/volume] in Serum

425

3161

1.31

6.47

1.7

1.5

25.35

21.40

iu/ml

0.14

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

281

1970

1.39

6.33

1.5

1.4

—

(3000492) Spirometry study

600

4683

1.25

6.24

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

570

4425

1.26

6.21

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

937

7693

1.20

5.92

1.6

1.4

—

(4146454) Self-monitoring of blood glucose

140

869

1.56

5.89

2.7

2.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

219

1491

1.43

5.87

1.5

1.4

0.28

0.30

mg/l

0.25

571

(1761482) Bacteria [#/volume] in Urine by Culture

347

2548

1.33

5.83

4.6

5.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

187

1241

1.46

5.75

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

301

2177

1.34

5.62

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1150

9652

1.17

5.61

3.5

3.8

41.15

20.53

ug/l

0.43

956

8062

(3014148) Varicella zoster virus Ab [Titer] in Serum

311

1.93

5.58

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

250

1763

1.38

5.49

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

327

2403

1.32

5.48

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

644

5154

1.22

5.33

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

326

1.87

5.20

1.4

1.3

1.25

1.24

nmol/l

0.02

238

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

223

1561

1.39

5.14

1.3

4.98

4.86

u/ml

0.03

252

(3024928) Oxygen saturation in Venous blood

292

2141

1.33

5.01

3.1

2.3

60.72

57.29

1.71

278

2044

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

231

1637

1.37

4.96

1.3

1.2

18.44

41.81

u/ml

1.27

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

548

1.64

4.92

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

456

3556

1.25

4.84

2.7

2.3

1.36

1.06

g/l

0.49

367

2952

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

574

1.62

4.81

1.3

1.2

1.22

1.51

nmol/l

2.37

510

(3000570) Elastase.pancreatic [Mass/mass] in Stool

310

2307

1.31

4.80

1.5

1.4

254.37

262.36

ug/g

0.29

179

1417

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

219

1557

1.36

4.64

1.3

1.2

19.98

4.06

u/ml

0.45

163

(3000285) Sodium [Moles/volume] in Blood

192

2.06

4.53

1.7

1.3

137.77

138.32

mmol/l

0.35

161

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

157

1059

1.44

4.52

1.6

1.4

0.86

0.84

nmol/l

0.13

136

876

(40768800) Prostate Pathology biopsy report

223

1598

1.35

4.50

1.2

—

(3018572) Chloride [Moles/volume] in Blood

242

1757

1.34

4.48

6.0

105.08

104.80

mmol/l

0.39

225

1563

(3039000) Anion gap in Blood by calculation

242

1757

1.34

4.48

6.0

11.29

11.36

mmol/l

0.14

225

1562

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

121

781

1.50

4.37

2.0

2.4

1.69

1.70

u/field

0.01

423

(3021879) Hepatitis B virus core Ab [Presence] in Serum

377

2913

1.26

4.36

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

233

1691

1.34

4.34

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

151

1020

1.43

4.33

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

478

3801

1.22

4.27

1.5

1.64

1.62

0.18

386

3045

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

266

1975

1.31

4.23

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

194

1377

1.37

4.19

1.3

1.2

3.59

5.87

u/ml

0.45

101

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

350

2696

1.26

4.18

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

302

2289

1.28

4.12

2.3

124.52

125.25

g/l

0.21

239

1772

(3020191) Ethanol [Moles/volume] in Serum or Plasma

339

1.74

4.07

1.1

1.2

0.94

0.95

promille

0.01

254

(3004716) Salmonella sp identified in Stool by Organism specific culture

280

2107

1.29

4.05

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

228

1.91

4.04

1.6

1.9

—

(3024471) HLA-A [Type]

2.63

4.03

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

274

2065

1.29

3.92

1.6

34.35

34.80

u/ml

0.02

289

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

246

1828

1.31

3.92

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

274

2068

1.29

3.88

1.3

1.2

1.33

0.97

u/ml

0.21

188

(3024932) HLA-DR beta [Type]

2.64

3.88

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

280

1.79

3.88

2.1

2.5

4.87

4.97

kpa

0.26

280

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

281

1.79

3.84

2.2

2.5

10.54

9.96

kpa

0.40

281

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

555

1.55

3.82

1.1

1.2

100.16

100.44

pmol/l

0.02

555

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

446

3567

1.22

3.80

3.5

3.2

4.33

4.29

pmol/l

0.35

388

3075

(3037121) Protein [Mass/volume] in Urine

369

2895

1.24

3.78

2.5

2.8

827.15

624.97

mg/l

0.15

143

1160

(3003181) Sodium [Moles/volume] in Urine

265

2000

1.29

3.77

1.3

60.20

59.35

mmol/l

0.14

208

1612

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

217

1597

1.32

3.73

2.1

1.7

14.84

12.93

mg/l

0.41

195

1437

(3013139) Helicobacter pylori Ag [Presence] in Stool

519

4223

1.20

3.69

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

316

2445

1.26

3.67

4.0

3.6

1.47

1.89

index

0.95

163

1240

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

555

1.53

3.61

2.6

1.7

138.31

107.73

ng/l

0.68

555

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

207

1521

1.32

3.61

1.4

1.2

9.57

5.54

u/ml

—

(3042733) HLA Ab [Presence] in Serum

2.54

3.61

7.6

3.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

263

1996

1.28

3.60

3.0

2.4

1.95

1.84

mg/l

1.18

223

1717

(3027456) Digoxin [Moles/volume] in Serum or Plasma

392

3114

1.22

3.59

3.3

3.5

0.79

0.82

nmol/l

0.52

314

2528

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

132

904

1.41

3.58

1.2

1.1

—

(4133840) Spirometry

2.41

3.58

1.2

—

(3006462) Nitrate [Presence] in Urine

354

1.67

3.53

4.0

4.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

244

1842

1.28

3.49

2.8

2.9

451.86

889.81

u/ml

0.97

223

1663

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

154

1089

1.37

3.47

1.4

1.2

25.81

54.48

u/ml

2.32

125

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

845

1.42

3.47

1.6

0.92

0.88

g/l

0.08

666

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

128

878

1.41

3.46

1.8

1.7

27.31

26.81

u/ml

0.04

183

(3014765) Yersinia sp identified in Stool by Organism specific culture

245

1854

1.28

3.45

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

2.27

3.43

10.7

13.2

5.27

5.10

mmol/l

0.23

102

(42529406) Shigella sp [Presence] in Stool by Culture

245

1860

1.28

3.37

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

279

2153

1.26

3.35

1.1

110.45

170.43

titre

0.48

(4211845) Urine protein measurement

382

1.62

3.35

4.0

4.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

884

1.40

3.34

3.9

4.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

283

2196

1.25

3.25

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

175

1277

1.33

3.24

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

127

882

1.39

3.22

3.3

3.6

10.78

12.23

index

1.11

441

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

199

1480

1.30

3.22

1.2

1.3

44.28

39.67

u/l

0.25

165

1266

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

367

2931

1.22

3.22

2.7

2.2

0.18

0.03

g/l

0.87

330

2581

(4035726) Immunohistochemistry procedure

784

6673

1.15

3.20

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

137

965

1.37

3.20

3.3

3.5

59.66

58.79

0.16

105

798

(3027135) IgG subclass 1 [Mass/volume] in Serum

519

1.51

3.14

1.4

6.67

7.08

g/l

0.59

388

(3028192) IgG subclass 2 [Mass/volume] in Serum

519

1.51

3.14

1.4

2.74

2.90

g/l

0.33

393

(3024139) IgG subclass 3 [Mass/volume] in Serum

519

1.51

3.14

1.4

0.44

0.48

g/l

0.26

391

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

307

1.67

3.13

2.3

2.2

25.92

32.83

iu/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

271

1.71

3.12

1.4

97.76

85.10

umol/l

0.30

157

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

293

2298

1.24

3.08

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

406

1.57

3.08

2.0

2.1

1.98

1.93

u/field

0.03

269

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

117

809

1.40

3.07

1.2

66.40

62.51

u/l

0.24

104

700

(3026389) Candida sp identified in Specimen by Organism specific culture

139

989

1.36

3.06

1.5

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

425

3461

1.19

3.05

2.5

2.6

0.34

0.35

iu/ml

0.45

234

1918

(3051387) C reactive protein [Mass/volume] in Capillary blood

227

1732

1.27

3.03

4.2

3.9

28.81

30.25

mg/l

0.25

176

1288

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

1638

1.28

3.03

1.3

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

146

1051

1.34

2.99

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

352

2826

1.21

2.96

2.8

2.2

0.01

0.00

g/l

0.63

309

2424

(3042631) Mycobacterium sp identified in Specimen

170

1254

1.31

2.95

2.4

2.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

278

2180

1.24

2.94

1.3

1.5

7.97

19.60

iu/ml

—

(3000034) Microalbumin [Mass/volume] in Urine

646

1.44

2.94

3.4

2.9

48.06

30.48

mg/l

0.81

480

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

188

1407

1.29

2.94

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

164

1.88

2.87

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

296

2344

1.22

2.86

1.8

1.6

9.90

7.37

iu/ml

0.77

538

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

330

2644

1.21

2.85

2.9

2.3

0.00

g/l

-0.00

309

2416

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

113

788

1.39

2.84

3.6

2.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

153

1122

1.32

2.79

7.0

5.9

13.33

12.82

mg/l

0.59

142

1008

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

104

718

1.40

2.78

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

125

894

1.35

2.71

1.1

—

1.19

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

116

823

1.36

2.65

1.2

1.3

0.19

0.20

nmol/l

0.86

672

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

136

991

1.33

2.62

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

346

1.56

2.62

5.1

2.7

108.47

65.67

mg/l

0.56

227

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

155

1151

1.30

2.61

1.8

1.6

—

33.10

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

136

994

1.32

2.57

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

346

2815

1.19

2.57

1.3

244.78

239.33

u/ml

0.05

318

2555

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

433

1.50

2.56

5.2

5.4

186.55

106.59

u/ml

0.32

137

(4062490) Immunoglobulin typing, IgG

512

1.45

2.56

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

157

1.84

2.55

1.1

1.0

1576.40

1628.98

miu/ml

0.09

157

(3038071) Oxygen [Partial pressure] in Mixed venous blood

117

1.98

2.51

26.8

7.9

5.68

5.55

kpa

0.09

117

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

186

1427

1.26

2.45

1.3

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

144

1070

1.30

2.44

2.2

2.3

1.18

0.98

g/24h

0.54

597

(3023419) Bacteria identified in Sputum by Culture

146

1087

1.30

2.44

2.5

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

134

990

1.31

2.38

1.3

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

683

1.37

2.37

1.4

1.2

14.07

53.27

u/ml

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

160

1211

1.28

2.36

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

379

1.50

2.35

1.6

1.8

93.29

94.82

umol/l

0.11

379

(3004809) Band form neutrophils/Leukocytes in Blood

193

1496

1.25

2.34

3.5

3.6

1.48

1.52

0.06

161

1295

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

333

1.54

2.34

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

188

1455

1.25

2.32

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

1022

1.30

2.28

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

390

1.49

2.27

2.4

2.2

47.00

134.82

ug/min

0.78

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

164

1254

1.27

2.25

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

108

781

1.34

2.24

1.2

1.3

—

nmol/l

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

260

2090

1.21

2.24

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

260

2090

1.21

2.24

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

471

1.44

2.23

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

471

1.44

2.23

1.3

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

125

924

1.31

2.23

1.2

1.3

0.73

2.61

nmol/l

0.48

116

887

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

123

1.88

2.21

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

197

1544

1.24

2.19

1.7

18.76

19.53

iu/l

0.01

525

(44806118) Parainfluenza type 4 nucleic acid detection

117

860

1.32

2.18

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

117

860

1.32

2.18

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

117

860

1.32

2.18

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

117

860

1.32

2.18

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

662

1.36

2.15

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

189

1.69

2.13

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

189

1.69

2.13

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

189

1.69

2.13

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

189

1.69

2.13

1.3

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

126

941

1.29

2.10

1.2

1.3

0.12

0.26

nmol/l

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

421

1.45

2.10

1.1

27.11

30.16

u/l

0.22

367

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

227

1.62

2.10

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

1448

1.24

2.09

1.4

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

107

782

1.32

2.09

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

215

1710

1.22

2.09

1.2

1.3

—

(4034850) Laboratory test

261

2115

1.20

2.09

16.4

13.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

281

0.48

2.09

1.0

1.3

1.42

1.55

g/l

1.25

281

(3002079) Sodium [Moles/time] in 24 hour Urine

235

1.60

2.08

1.2

137.18

150.80

mmol/24h

0.62

235

(3017315) Amylase [Enzymatic activity/volume] in Urine

335

1.50

2.08

1.2

398.62

272.65

u/l

0.28

313

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

198

1.66

2.07

1.1

1.07

1.08

ratio

0.13

143

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

552

1.38

2.06

2.4

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

118

877

1.30

2.05

1.6

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

305

1.52

2.05

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

138

1048

1.27

2.04

1.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

136

1032

1.27

2.02

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

330

1.49

2.01

1.2

—

(3003129) Base excess in Capillary blood by calculation

125

940

1.29

2.00

2.9

2.5

1.18

0.55

mmol/l

0.79

118

898

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

378

1.46

1.99

1.8

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

378

1.46

1.99

1.8

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

378

1.46

1.99

1.8

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

680

1.34

1.99

1.0

1.1

73.90

754.72

iu/ml

0.80

105

(3011335) Digoxin [Mass/volume] in Serum or Plasma

114

1.86

1.98

2.9

2.5

0.72

0.65

ug/l

0.36

114

(3040151) Glucose [Moles/volume] in Capillary blood

147

1130

1.26

1.97

15.0

7.1

7.74

7.33

mmol/l

0.80

120

929

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

428

1.42

1.95

1.1

92.27

86.85

u/l

0.23

374

(3006571) Granulocytes/Leukocytes in Synovial fluid

125

949

1.27

1.88

1.6

1.5

64.58

62.54

0.28

592

(3038026) Centromere Ab [Units/volume] in Serum

513

1.37

1.87

1.2

—

49.79

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.62

1.86

85.0

11.0

103.17

109.44

g/l

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

646

1.33

1.86

1.6

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

646

1.33

1.86

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

646

1.33

1.86

1.6

1.4

—

(3044927) Protein electrophoresis panel - Urine

135

1036

1.26

1.86

1.2

—

(36660697) Celiac disease serology panel - Serum

508

4376

1.13

1.83

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

213

1.59

1.83

1.1

1.2

1.89

1.40

mmol/l

0.81

135

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

379

1.43

1.79

1.9

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

213

1723

1.20

1.79

1.7

1.4

0.24

0.23

g/l

0.61

200

1618

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

485

1.37

1.78

3.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

149

1164

1.24

1.77

1.7

4.05

4.40

mmol/24h

0.64

121

969

(3036489) Thrombin time

283

2351

1.17

1.74

2.1

1.8

22.83

21.54

0.74

256

2163

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

194

1.59

1.71

1.7

1.4

18.56

16.80

pmol/l

1.00

148

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

391

1.41

1.71

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

327

1.45

1.70

6.1

6.3

25.13

177.37

ug/l

0.87

201

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

217

1768

1.19

1.70

1.7

1.5

1.16

g/l

0.11

206

1663

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.01

1.70

1.1

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

425

3645

1.13

1.67

2.2

2.1

11.09

11.27

nmol/l

0.15

350

3097

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

223

1827

1.18

1.64

2.5

2.1

3.59

3.65

g/l

0.21

211

1728

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

137

1.69

1.62

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.85

1.62

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

101

764

1.28

1.61

1.6

1.3

250598.11

225332.75

e6/l

0.09

502

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

230

1.51

1.56

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

178

1438

1.20

1.56

1.1

80.00

139.45

titre

2.02

110

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

375

3213

1.13

1.52

1.3

57.67

59.02

au/ml

0.04

211

(3034274) Bile acid [Moles/volume] in Serum --fasting

271

1.46

1.52

1.2

1.3

8.93

11.44

umol/l

0.43

186

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.02

1.51

2.3

2.7

87.08

67.57

mg/l

—

(3024263) Appearance of Synovial fluid

393

1.38

1.51

1.7

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

413

3564

1.12

1.50

2.5

19.33

23.43

au/ml

0.27

210

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

361

1.39

1.49

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

486

1.33

1.47

1.3

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

234

1.48

1.46

1.3

1.2

6.23

6.28

mmol/l

0.08

218

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

462

1.34

1.45

1.1

1.2

76.25

146.35

titre

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

1.69

1.44

1.1

—

(21494755) Public health laboratory ask at order entry panel

659

0.73

1.43

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

220

1.49

1.42

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

114

1.69

1.39

2.6

2.9

0.25

0.54

u/field

1.28

114

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.08

1.38

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

144

1658

0.83

1.38

2.2

2.0

3.05

3.25

ratio

1.48

126

1356

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.76

1.36

6.9

7.4

9.85

10.23

0.23

(3002619) Bacteria identified in Specimen by Culture

191

1.52

1.36

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.79

1.35

4.3

5.6

—

(3014271) Vancomycin [Susceptibility]

689

1.26

1.35

3.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.34

0.0

4.2

—

0.00

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

562

1.29

1.33

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

478

1.31

1.33

1.4

1.2

114.08

92.76

u/l

0.89

400

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

463

1.31

1.30

1.4

1.2

44.90

29.99

u/l

0.65

375

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.10

1.28

1.1

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

712

1.25

1.27

1.6

1.3

52.86

60.67

titre

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

507

1.29

1.27

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

191

1586

1.16

1.26

1.8

2.0

30.06

31.49

umol/l

0.54

154

1361

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

199

1659

1.16

1.25

2.4

2.0

90.43

88.87

0.50

189

1589

(3022689) Creatine [Moles/volume] in Urine

187

1.50

1.25

1.7

1.4

6.29

6.54

mmol/l

0.11

187

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.41

1.24

1.2

2.0

—

(3021788) Differential panel - Synovial fluid

184

1527

1.16

1.23

1.5

—

1.00

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.48

1.22

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

301

1.38

1.22

1.8

592.03

502.61

e6/l

0.37

247

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

142

1.56

1.21

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

735

1.24

1.20

1.5

1.3

68.33

307.82

titre

2.50

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

127

1.59

1.20

1.3

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

158

1.53

1.19

1.1

1.2

26.63

269.82

u/l

0.61

104

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1119

0.82

1.19

2.1

1.8

3.05

3.22

mmol/l

0.65

820

(3016038) Potassium [Moles/volume] in Urine

711

1.24

1.18

1.1

34.90

35.66

mmol/l

0.13

590

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

353

1.34

1.18

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

206

1.45

1.17

1.2

1.4

13.40

14.85

g/l

0.41

156

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

145

1187

1.18

1.17

1.1

33.88

14.13

eliau/ml

—

(40762814) Titanium [Mass/volume] in Blood

159

1.52

1.16

2.4

2.2

2.53

3.74

ug/l

—

(3034770) Mitochondria Ab [Titer] in Serum

176

1465

1.16

1.15

1.1

1346.67

928.26

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

363

1.33

1.15

1.6

1.9

37.95

39.38

g/l

0.85

363

(40768441) Liver Pathology biopsy report

422

1.30

1.14

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

176

1.48

1.13

1.1

1.3

138.42

138.72

nmol/l

0.00

119

(3010726) Horse dander IgE Ab [Units/volume] in Serum

224

1.42

1.13

1.0

1.1

0.04

0.29

u/ml

2.53

127

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

365

0.69

1.13

1.2

1.3

456.71

322.50

ug/l

0.14

195

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

570

1.25

1.10

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

112

903

1.20

1.09

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.66

1.07

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

155

1.49

1.06

1.0

1.2

206.72

266.93

pmol/l

0.81

107

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.68

1.06

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

277

1.36

1.05

2.0

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

277

1.36

1.05

2.0

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

236

1.39

1.05

1.1

—

(3008898) HLA-B27 [Presence]

113

916

1.19

1.04

1.1

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

115

935

1.19

1.03

1.3

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

848

1.20

1.02

1.2

325.84

259.67

pmol/l

1.08

694

(3002523) Influenza virus A Ag [Presence] in Specimen

312

1.33

1.02

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

239

2054

1.12

1.02

1.7

1.6

13885.74

15819.52

e6/l

0.40

168

1413

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

157

1.47

1.01

1.1

—

7.47

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

253

0.65

1.00

2.2

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

640

5768

1.07

1.00

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

105

851

1.19

0.99

1.1

—

14.26

—

(40757373) Influenza virus identified in Isolate

190

1.42

0.98

1.3

1.4

—

(3035880) pH of Pleural fluid

614

1.23

0.98

1.3

7.42

0.03

422

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

755

1.20

0.97

1.7

1.2

157.35

163.72

au/ml

0.23

225

(44813793) Dust mix specific IgE antibody measurement

290

1.33

0.96

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

165

1391

1.15

0.96

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

282

1.33

0.96

2.1

1.6

—

(3020491) Glucose [Moles/volume] in Blood

478

1.25

0.95

2.7

2.3

7.40

7.10

mmol/l

0.35

326

(3003740) Influenza virus B Ag [Presence] in Specimen

316

1.31

0.95

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

233

2010

1.12

0.95

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

200

1.40

0.94

2.2

1.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

342

1.30

0.94

1.4

3.12

1.16

u/ml

0.49

213

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.65

0.93

1.2

6230.58

232.58

ng/l

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

1.61

0.92

2.1

3.1

1.93

2.05

0.09

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

108

1219

0.85

0.91

1.2

4.00

3.86

mmol/l

0.57

103

1134

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

806

1.19

0.90

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

100

0.48

0.89

25.4

15.5

2073.20

1347.73

nmol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

532

0.78

0.89

1.1

1.0

676.12

685.15

ng/l

0.04

319

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

532

0.78

0.89

1.1

1.0

35.28

45.22

ng/l

1.10

327

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

256

0.68

0.88

1.1

1.8

22565.00

24374.36

e6/l

0.04

136

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

531

0.78

0.88

1.1

1.0

265.35

339.52

ng/l

1.52

332

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.88

0.87

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

172

1.40

0.84

5.9

5.6

8.62

8.55

mmol/l

0.05

172

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

164

1.41

0.84

1.5

1.2

1.82

3.52

u/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

247

1.33

0.83

1.1

1.2

28.97

11.42

pmol/l

0.43

(40768446) Kidney Pathology biopsy report

165

1.40

0.82

1.7

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

106

1185

0.86

0.82

1.5

1.3

119.08

32.36

e6/l

0.35

898

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

323

2862

1.09

0.81

1.1

1.2

120.45

123.17

u/ml

0.04

111

927

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

376

1.26

0.81

1.1

1.50

0.76

u/ml

0.39

210

(3003434) Protein [Mass/volume] in Pleural fluid

196

1694

1.12

0.81

1.4

1.5

29.80

30.76

g/l

0.53

180

1512

(3045788) Cell count panel - Pleural fluid

140

1185

1.14

0.80

1.4

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

249

1.32

0.80

3.1

6.0

77.58

69.47

1.58

190

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

334

1.27

0.80

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

199

1.36

0.79

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

107

1192

0.86

0.79

1.6

1.4

583.53

1077.31

e6/l

0.82

964

(3033099) Centromere Ab [Titer] in Serum

134

1.44

0.78

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.1

—

39.41

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

457

1.22

0.77

1.3

1.5

7.83

7.08

u/l

0.18

359

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

633

1.19

0.77

1.0

1.1

16.88

29.73

au/ml

—

(3011985) Renin [Units/volume] in Plasma

109

910

1.16

0.77

1.2

1.3

53.39

57.09

mu/l

0.06

800

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

127

1.44

0.76

1.1

89.15

90.41

0.07

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

724

1.17

0.75

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

202

1.34

0.74

2.3

1.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

186

1.35

0.72

1.6

2.2

7.29

7.42

mmol/l

0.07

130

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.61

0.72

1.2

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

728

1.17

0.71

1.7

1.5

23.53

28.09

0.81

458

(3026470) Cobalt [Mass/volume] in Blood

577

1.19

0.71

2.1

5.11

4.03

ug/l

0.44

528

(3035933) Granulocytes/Leukocytes in Blood

159

1372

1.12

0.70

3.3

3.2

60.42

59.40

0.45

159

1372

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

272

1.28

0.70

1.3

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

171

1.35

0.69

1.0

1.3

—

2108280.00

—

(37021550) Renin [Units/volume] in Plasma --upright

138

1.40

0.69

1.1

1.3

28.37

78.67

mu/l

2.63

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.56

0.68

1.1

1.5

—

(3004451) EKG impression Narrative

571

1.18

0.68

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

180

1.34

0.68

1.5

1.4

0.11

0.13

nmol/l

0.63

116

(3036525) Urea [Moles/time] in 24 hour Urine

1.65

0.67

2.3

3.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.63

0.67

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

172

1.35

0.67

1.3

1.19

1.17

mmol/l

0.57

172

(37208534) Antinuclear antibody arbitrary concentration in serum

164

1.35

0.66

1.1

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.53

0.66

18.6

11.2

1060.60

744.14

nmol/l

—

(40762365) Oxygen content in Arterial blood by calculation

131

1.40

0.66

3.4

2.6

15.29

14.39

ml/dl

0.77

121

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

309

1.25

0.66

2.1

2.5

33.24

36.92

0.46

178

(3036670) Protein [Mass/volume] in Synovial fluid

292

1.26

0.66

1.2

40.96

39.73

g/l

0.20

135

(4198724) Urine methamphetamine measurement

1.61

0.65

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

232

1.29

0.65

2.2

2.3

0.60

0.62

mmol/l

0.65

232

(3023199) Leukocytes [#/volume] in Pleural fluid

170

1481

1.11

0.65

1.3

1.5

4960.79

2704.13

e6/l

0.24

117

1041

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

149

0.65

7.6

7.3

13.66

13.70

—

149

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

140

1.38

0.64

1.4

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

319

1.24

0.64

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

691

1.16

0.64

1.6

1.5

—

(21494434) Karyotype in Bone marrow

772

1.15

0.64

1.1

—

(3004775) Volume in Urine collected for unspecified duration

593

1.17

0.64

2.5

2.1

550.47

639.92

1.61

377

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

227

0.72

0.63

2.9

1.9

54.97

44.56

u/l

0.13

212

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

249

0.73

0.63

1.9

2.1

43.46

52.85

umol/l

0.61

203

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.72

0.63

3.6

4.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

1182

1.12

0.63

5.0

3.6

309.00

2939.77

iu/ml

0.96

160

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

309

2773

1.08

0.62

1.1

1.44

1.27

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

217

1.29

0.62

1.7

—

(3011412) CD3 cells [#/volume] in Blood

488

1.19

0.62

1.9

1.8

1118.42

1044.79

e6/l

0.33

438

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

109

929

1.13

0.61

2.3

2.0

372.40

1747.21

u/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.66

0.61

1.0

1.1

235.80

260.38

nmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

659

1.16

0.61

1.7

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

180

1581

1.10

0.60

2.9

2.2

221.98

217.51

0.27

172

1489

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.58

0.60

1.0

1.1

—

(3012565) Volume of 24 hour Urine

331

1.22

0.60

2.1

2.3

1752.86

1784.91

0.09

276

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

696

1.15

0.60

1.4

1.1

301.70

288.25

u/ml

0.15

399

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

553

1.17

0.59

2.0

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

1.51

0.58

1.1

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

725

1.14

0.58

1.6

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

492

1.18

0.58

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

151

1319

1.11

0.57

1.3

1.4

90461.02

59285.03

e6/l

0.23

748

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

377

1.20

0.57

3.1

2.2

—

(3017704) Immunofixation for Urine

520

1.17

0.56

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

114

982

1.12

0.56

1.8

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

299

1.23

0.56

1.0

1.1

0.85

1.07

u/ml

0.18

125

(3000093) Morphology [Interpretation] in Blood Narrative

103

882

1.13

0.56

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

0.69

0.55

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

451

1.18

0.54

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

451

1.18

0.54

1.3

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

595

1.15

0.53

1.7

178.41

184.19

pmol/l

0.27

543

(3023487) Leukocytes [#/volume] in Peritoneal fluid

284

0.78

0.53

2.0

1.8

602.53

4164.30

e6/l

0.64

184

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

164

0.70

0.53

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

750

1.13

0.52

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.18

0.52

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

391

1.18

0.51

1.3

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

250

1.23

0.51

1.4

14.68

22.89

1.37

201

(3016750) Collection duration of Urine

409

1.18

0.51

2.1

2.0

513.56

501.07

min

0.48

293

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

409

1.18

0.51

1.3

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

242

1.24

0.50

1.8

1.4

70.91

59.43

1.15

209

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

644

1.14

0.50

1.2

3.30

4.08

u/ml

0.28

223

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.50

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

313

1.20

0.49

1.9

0.61

e9/l

0.04

287

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

269

1.22

0.49

1.4

1.6

3.09

8.05

nmol/l

1.25

235

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

191

1.26

0.48

1.4

1.3

31.47

32.83

0.07

127

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

655

1.13

0.48

1.7

5.44

4.77

mg/l

0.37

618

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

104

0.65

0.48

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.53

0.48

1.1

1.2

96.00

104.73

titre

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

628

1.14

0.48

1.1

1.2

4.24

4.50

u/ml

0.07

292

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

215

0.76

0.48

1.5

1.2

—

(3025577) Chromium [Mass/volume] in Blood

565

1.14

0.48

2.1

2.43

2.29

ug/l

0.11

470

(40768793) Breast Pathology biopsy report

180

1605

1.08

0.47

1.3

—

(4212803) Bone marrow aspirate examination

1.39

0.47

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

405

1.17

0.46

1.3

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

307

1.19

0.46

1.0

0.93

1.49

u/ml

0.52

137

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.61

0.45

3.8

2.6

—

110.56

ng/l

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

130

1145

1.10

0.45

1.3

450.65

358.00

u/l

0.27

124

1083

(4094501) Cardiovascular stress test using bicycle ergometer

175

1562

1.08

0.45

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

133

1.30

0.45

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

389

1.17

0.44

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

398

1.16

0.44

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.44

1.1

1.0

—

(4195642) Thrombophilia screening test

543

1.14

0.43

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

134

1.30

0.43

1.1

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

169

1.26

0.42

1.2

2.44

1.72

mmol/l

0.13

106

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

773

1.11

0.42

1.2

1.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.21

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.41

0.0

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.51

0.41

1.0

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

170

1.25

0.41

30.1

26.6

106.67

103.84

ug/l

0.12

139

(3020650) Glucose [Presence] in Urine

179

1.24

0.40

1.4

1.9

0.00

0.02

estimate

0.50

179

(3006270) Folate [Moles/volume] in Blood

740

1.11

0.39

1.2

304.92

315.15

nmol/l

0.19

545

(3008295) Osmolality of Serum or Plasma

108

952

1.09

0.39

1.3

274.32

273.55

mosm/kgh2o

0.12

663

(40768795) Lymph node Pathology biopsy report

731

1.11

0.39

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.31

0.39

1.4

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.31

0.39

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.31

0.39

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.31

0.39

1.4

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

122

1082

1.09

0.39

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

772

0.90

0.38

1.0

—

(3034426) Prothrombin time (PT)

120

1.29

0.37

1.1

1.2

28.06

28.16

0.03

120

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

252

1.19

0.37

1.0

1.1

6.45

12.80

iu/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

378

1.15

0.37

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

606

1.11

0.36

1.5

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

485

0.87

0.36

1.0

1.1

—

4.24

—

(3028433) Virus identified in Specimen by Culture

200

1.21

0.35

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

321

3236

0.95

0.35

3.5

4.2

89.30

97.48

u/ml

0.13

300

3091

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

1.22

0.35

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

317

1.16

0.34

1.7

1.4

7.24

6.28

u/l

0.23

259

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

858

1.09

0.34

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

113

1.28

0.34

1.1

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.31

0.34

1.1

0.41

0.76

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

328

0.85

0.34

1.3

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

693

1.10

0.33

1.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

379

0.86

0.33

1.0

1.1

—

(3019174) dRVVT (LA screen)

1.31

0.33

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

167

1513

1.06

0.33

1.2

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

429

1.12

0.32

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

420

1.12

0.31

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

211

0.82

0.31

1.4

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

485

1.11

0.31

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.28

0.30

1.2

1.5

57.23

48.59

umol/l

0.49

(21494814) CD8 cells/Lymphocytes in Specimen

231

1.17

0.30

1.9

1.8

22.57

32.46

3.75

231

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.25

0.29

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

116

1.25

0.29

1.7

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

387

1.12

0.28

3.1

3.3

0.84

1.23

1.51

387

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

167

0.81

0.28

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

1.27

0.28

1.2

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

122

1102

1.07

0.28

1.4

6.61

6.36

mmol/l

0.46

117

1032

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

572

1.10

0.28

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

112

0.77

0.27

1.0

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.24

0.27

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

1.24

0.27

2.0

2.2

1010.13

505.75

umol/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

499

1.10

0.27

1.2

8.60

8.08

mmol/l

0.42

388

(3008536) Aspergillus sp Ab [Presence] in Serum

144

1.21

0.27

1.4

—

(4015189) Microbial culture of sputum

234

1.15

0.27

1.8

2.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.24

0.25

1.4

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

163

0.83

0.24

1.6

1.3

138.40

141.55

pmol/l

0.04

163

(3001729) Color of Synovial fluid

1.26

0.24

2.7

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

128

1167

1.06

0.24

1.4

1.5

163.21

298.05

pmol/l

3.02

121

1123

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

541

1.09

0.23

1.1

111.08

113.48

0.19

461

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

111

1.22

0.23

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

192

1.15

0.23

1.1

—

(3016879) Cocaine [Presence] in Urine

156

1.17

0.23

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

162

0.83

0.22

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.24

0.22

1.0

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

103

1.22

0.21

17.2

11.7

0.56

0.67

mmol/l

0.75

(3005532) Lymphocytes/Leukocytes in Pleural fluid

414

1.09

0.21

1.3

1.5

76.65

68.02

1.20

331

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.12

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

6.13

—

(3039443) Prostate specific Ag panel - Serum or Plasma

544

0.92

0.21

1.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

1.47

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.27

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

494

0.92

0.21

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

119

0.81

0.21

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

185

1.15

0.20

1.0

1.1

0.17

1.19

u/ml

2.82

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.26

0.20

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

231

1.13

0.20

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

131

1.18

0.20

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

113

1.19

0.20

1.4

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.20

0.19

1.0

20.33

30.09

iu/ml

—

(44806071) Cardiolipin IgM antibody measurement

1.20

0.19

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

352

1.10

0.19

1.4

32.53

37.60

iu/l

0.40

292

(4027681) Cerebrospinal fluid IgG ratio and IgG index

168

1.15

0.19

1.4

1.2

0.53

0.52

ratio

0.07

100

(3027008) Opiates [Presence] in Urine

159

1.15

0.19

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

160

1.14

0.17

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

326

1.09

0.17

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

130

1201

1.04

0.17

1.7

1.8

20.24

23.85

ug/l

0.76

121

1168

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.72

0.16

1.0

1.1

1.99

1.72

umol/24h

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

683

1.06

0.16

1.3

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

134

1.15

0.16

1.1

1.0

15.58

24.18

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

694

1.06

0.15

1.1

1.57

1.58

g/l

0.05

617

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

236

1.10

0.15

1.2

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.81

0.14

1.0

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.79

0.14

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

434

0.93

0.14

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

154

1.13

0.14

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

191

1.11

0.14

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

324

0.92

0.14

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

182

1.11

0.13

1.0

1.1

0.12

1.03

u/ml

1.81

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.19

0.13

1.2

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

123

0.86

0.13

1.8

2.5

7208.36

1725.94

u/l

0.34

117

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

304

1.08

0.13

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

0.89

0.12

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

653

1.05

0.12

1.4

1.3

10.10

13.27

u/l

1.38

511

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

332

0.93

0.12

1.8

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

202

1.10

0.12

1.7

1.6

0.41

0.40

ug/l

0.05

125

(40768806) Pleura Pathology biopsy report

136

1270

1.03

0.12

1.5

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

156

1.11

0.12

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

340

3218

1.02

0.11

2.5

3.0

278.39

1918.66

u/ml

2.94

277

2725

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

486

1.05

0.10

1.1

249.72

179.30

miu/ml

0.38

(3032773) Endomysium IgG Ab [Titer] in Serum

468

1.05

0.10

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

781

1.04

0.10

1.7

1.6

53.04

48.70

nmol/l

0.78

736

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

102

1.13

0.10

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

130

1.11

0.09

1.5

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.07

0.09

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

177

1.09

0.09

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.05

0.09

1.0

1.1

0.08

0.03

u/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

224

1.08

0.09

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

109

1021

1.03

0.09

1.7

1.6

4.74

5.07

mg/l

0.09

803

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

347

1.06

0.09

2.9

219.29

213.32

u/l

0.22

341

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

105

984

1.03

0.08

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

376

1.05

0.08

1.1

0.94

13.88

nmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.79

0.08

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.02

0.07

1.0

1.3

—

181.91

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

843

0.97

0.07

3.9

3.8

312.82

325.76

umol/l

0.36

697

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.03

0.07

1.0

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

187

0.93

0.07

1.6

1.5

12.14

8.40

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.01

0.07

1.9

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.04

0.07

1.7

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

245

0.94

0.06

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

162

1.07

0.05

1.0

0.03

0.23

u/ml

1.67

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

248

1.05

0.05

1.1

334.33

294.54

mg/l

0.54

217

(4268621) Lupus anticoagulant assay

439

1.03

0.05

2.1

2.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

135

0.93

0.04

2.2

1.7

10.61

10.11

ug/l

0.13

135

(3037692) Legionella sp identified in Specimen by Organism specific culture

262

0.96

0.04

1.4

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

125

0.92

0.04

1.2

1.7

1.11

1.12

ug/l

0.01

115

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

125

0.92

0.04

8.7

4.0

36.92

54.30

u/l

0.63

118

(44806420) Estimation of glomerular filtration rate

431

1.03

0.04

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

105

996

1.02

0.04

2.9

3.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

173

0.95

0.03

2.1

3.71

232.59

ug/l

0.76

173

(3001964) Herpes simplex virus Ag [Presence] in Specimen

165

1.05

0.03

1.4

1.2

—

(3014891) Appearance of Pleural fluid

194

1.04

0.02

1.7

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

259

0.97

0.02

1.4

1.2

—

(3025130) Human papilloma virus identified in Specimen

386

1.02

0.02

1.7

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

559

0.98

0.02

2.1

1.9

304.60

332.05

mu/l

0.22

510

(4281824) Cell count and differential, peritoneal fluid

781

0.99

0.02

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

646

1.01

0.02

1.5

1.2

—

(3023410) Appearance of Cerebral spinal fluid

500

0.98

0.02

1.6

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

244

1.03

0.01

3.6

2.8

26.46

28.86

umol/l

0.70

182

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

284

0.98

0.00

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

523

0.99

0.00

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

149

1.03

0.00

1.0

1.1

0.69

0.66

umol/24h

—

(3035320) C reactive protein [Mass/volume] in Body fluid

580

1.00

0.00

3.5

2.9

22.12

31.23

mg/l

1.80

444

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

885

1.00

0.00

1.2

1.3

11.25

14.43

u/l

0.90

799

(3016018) Differential panel - Cerebral spinal fluid

577

1.00

0.00

1.6

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.98

0.00

1.0

1.5

24.50

15.45

mm/h

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

195

0.99

0.00

1.2

1.0

1.06

1.19

u/l

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

439

1.01

0.00

1.1

86.53

91.25

0.53

396

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

177

0.98

0.00

1.0

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

374

1.00

0.00

1.6

1.5

4.38

3.30

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

178

1.03

0.00

1.2

1.4

180.21

407.85

nmol/24h

0.54

178

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

444

1.00

0.00

1.0

1.1

11.70

3.46

eliau/ml

0.41

(1002224) Polysomnography panel

116

1117

1.00

0.00

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.96

0.00

1.3

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.86

0.00

12.2

14.1

0.30

0.24

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.93

-0.00

1.1

2.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

3188.63

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.3

—

18.19

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.94

-0.00

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.90

-0.00

1.3

1.8

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.90

-0.00

1.8

1.7

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.97

-0.00

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

1.62

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

74.94

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

2.54

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

260.00

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.0

—

5.80

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.88

-0.00

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.90

-0.00

1.2

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint WET_AMD and mortality.

Females

Parameter	HR [95% CI]	p-value
WET_AMD	0.833 [0.76, 0.91]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.306

During the follow-up period (1.1.1998 — 31.12.2019), 11318 out of 30853 females with WET_AMD died.

Males

Parameter	HR [95% CI]	p-value
WET_AMD	0.905 [0.81, 1.01]	0.064
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 6694 out of 16881 males with WET_AMD died.

Mortality risk

Mortality risk for people of age

years, who have WET_AMD.

N-year risk	Females	Males
1	0.084%	0.179%
5	0.505%	0.921%
10	1.256%	2.546%
15	2.328%	4.81%
20	4.171%	8.311%

Relationships between endpoints

↥

Index endpoint: WET_AMD – Wet age-related macular degeneration

GWS hits: 33

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Wet age-related macular degeneration

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints